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Abstract
The structural and functional changes in the arterial wall of humans and animals
accompany the development of hypertension and atherosclerosis. Hence, great interest

exists in the mechanisms that govern vascular smooth muscle cell contraction and

proliferation. Rat aortic rings maintained in organ culture show a significant loss of
contractility; whereas, vascular smooth muscle cells in culture quickly dedifferentiate into

a secretory phenotype with a marked capacity for proliferation. The addition of all-trans

retinoic acid (RA) and retinol to the plasma-containing medium preserved the contractile

response of cultured vessels. Removal of endothelium prior to culture abolished these
effects. All-trans retinoic acid but not retinol inhibited A7r5 smooth muscle cell growth;

whereas, retinol significantly inhibited A7r5 cell growth in the presence of bovine aortic

endothelial cells (BAEC). Conditioned medium from BAEC treated with retinol also
inhibited A7r5 cell growth and several metabolites of retinol were found released by

BAEC in HPLC analysis.

A7r5 smooth muscle cells express five PKC isozymes. RA treatment increased
the expression of PKCa, 8, and e. Overexpression of PKCa in A7r5 cells was used to
elucidate its role in the regulation of smooth muscle cell differentiation. Overexpressing
clones had altered morphology and decreased growth rates. Cell differentiation marker

proteins such as vinculin and desmin were not affected by PKCa overexpression;

whereas, the expression of smooth muscle-specific a-actin was markedly reduced. These
findings suggest that PKCa may regulate growth independently from differentiation.

iv
The results suggest that circulating factors, such as retinol and retinoic acid, may
be necessary for the maintenance of the differentiated state of smooth muscle. Retinol

appears to exert its effects primarily on the endothelium, which in turn secretes stable
factors that affect smooth muscle phenotype. The regulatory effect of RA may involve

PKC. Individual isoforms of PKC may play different roles in regulating smooth muscle
cell proliferation and contraction.
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Literature Review

Cardiovascular disease is the greatest scourge afflicting populations of the
industrialized nations. It not only strikes down a significant fraction of the population
without warning but causes prolonged suffering and disability in even larger numbers. In

the United States alone, despite recent encouraging declines, cardiovascular disease is still
responsible for almost one million fatalities each year and more than one half of all
I

deaths; almost 5 million persons afflicted with cardiovascular disease are hospitalized
each year. The cost of this disease in terms of human suffering and of material resources

is almost incalculable.
Hypertension and atherosclerosis are two major forms of cardiovascular disease.
Hypertension poses a major public health problem. It affects more than 50 million people,

contributing to more than 0.5 million strokes and 1.25 million coronary attacks per year
in the United States (Barrie, 1996). Atherosclerosis is the most common disease that

afflicts Western society. It is the underlying cause of most cardiovascular disease,
including myocardial infarction and cerebrovascular insufficiency. Deregulated smooth

muscle cell proliferation has been correlated with atherosclerosis and hypertension as well
as restenosis after angioplasty, a therapeutic method for widening narrowed arterial

lumen.

1. Smooth Muscle Cell Proliferation in the Etiology of Cardiovascular Diseases
Cells of vessel walls are derived almost entirely from mesoderm and are organized

1

into several layers. The major layers of the vessel wall include the tunica intima, tunica

media, and tunica adventitia. The tunica intima, the innermost layer, is composed of
endothelial cells. Tunica intima is surrounded by a tunica media, which is composed of

many layers of smooth muscle cells and forms the bulk of the vessel wall. The tunica
media, in turn, is surrounded by a layer of connective tissue, the tunica adventitia. The

tunica adventitia is comprised of loose connective tissue containing smaller blood vessels
and nerves.
The principal function of smooth muscle cells in mature animals is contraction.
They maintain the lumen diameter of blood vessels by contracting or relaxing in response

to changes in the plasma environment or in response to endothelial secretory and neural

activity. Thus, smooth muscle contractility plays a central role in controlling resistance to
flowthrough small arteries. Abnormal responses to different vasoactive stimuli may result
in a narrowed lumen of small arteries, which further increases the flow resistance, causing

an elevation of blood pressure. A variety of observations over an animal model suggest

the possibility that inborn errors account for altered smooth muscle function in

hypertension. For example, increased vessel shortening velocity and decreased relaxation
rate in response to various stimuli (Packer, 1997; Fuchs et al., 1996), and increased

sensitivity of myofilaments to Ca++ (Shaw et al., 1997), have been reported in arterial
smooth muscle cells in spontaneously hypertensive rats (SHR). Also, changes in myosin
ATPase activity rather than changes of the myosin content were found in SHR, which may
explain the increased contractility of smooth muscle cells in the hypertensive rat (Packer,

2

1997).

Structural changes in vessels may further contribute to the etiology of

hypertension. Blood pressure is the product of cardiac output and total peripheral
resistance. According to Poiseuille’s law, R=8L/7rr4 (R=resistance; L=length; r =radius

of vessel). As the resistance is inversely related to the fourth power of vessel radius, it is
particularly true that a very small, fixed change in the ratio of wall thickness to internal
radius can produce a dramatic change in vascular resistance and thus blood pressure. It
is estimated that a 5% decrease in the average internal radius of resistance vessels is

capable of producing a 25% increase in peripheral resistance (Folkow, 1982). In chronic
hypertension, it has been shown that thickening of the vessel wall results in vessel lumen
narrowing (Tracy, 1970; Halpern et al., 1978), and the resistance to flow through

peripheral vessels of humans and animals with hypertension is increased even when the
vessel wall is totally relaxed. Folkow (1982) estimated that the average internal radius of

the vessels of hypertensive rat is narrowed by 6-7%, while the vessel wall is about 35%
thicker than in a normotensive rat. Morphometric studies by Mulvany

(1991)

demonstrated that the hypertensive vessel wall (in both essential and secondary

hypertension) are thicker than normal vessel walls, and this thickening has been observed
to occur before an elevation in blood pressure is detected (Eccleston-Joyner and Gray,

1988; Lee et al., 1987; Dickhout and Lee, 1997). The change in smooth muscle mass can
be caused either by hypertrophy or hyperplasia of smooth muscle cells. Increased smooth
muscle cytoplasm volume (Wiener et al., 1977), cell number (Mulvany et al., 1985;

Dickhout and Lee, 1997), or smooth muscle cellular hyperploidy (Owens and Schwartz,
3

1982) have been shown in hypertensive animals. Vascular smooth muscle cells isolated
from spontaneously hypertensive rats proliferate faster than those isolated from

normotensive Wistar-Kyoto rats (Yamori et al., 1981; Resink et al., 1987; Hamet et al.,
1988; Bunkenberg et al., 1992). The difference is probably due to increased

responsiveness to growth factors (Saltis et al., 1993). They are also less sensitive to
heparin-induced growth inhibition (Resink et al., 1989). These findings indicate that
hypertensive animals may be genetically determined to have a thickened vessel wall due

to either smooth muscle cell hyperplasia or hypertrophy, resulting in higher total vascular
resistance to blood flow.

The development of atherosclerosis in humans is a slow process that occurs over

decades and is characterized by the focal formation of atheromatous plaques in the intima
of medium and large arteries. Atheromatous plaques are made of a lipid core and a fibrous
cap accounting for 25% and 75% of the lesion, respectively. The cellular composition of

atherosclerotic plaques has been identified by immunochemistry (Jonasson et al., 1986).

The lipid core contains a predominant proportion of macrophages (60%), 30% smooth

muscle cells, and 10% lymphocytes. By contrast, the fibrous cap is constituted mainly of
smooth muscle cells (60%), 23% macrophages, 17% lymphocytes, and a few polynuclear

leukocytes. Deregulated smooth muscle cell proliferation has been shown to be highly
correlated with atherosclerosis. Focal masses of smooth muscle cell proliferation have
been observed in the intimal layer of vessels in both animal and human atherosclerotic

lesions, and it was found that this proliferation happened prior to an accumulation of
4
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lipids (Ross and Glomset, 1976). Although it still remains controversial whether smooth
muscle cell growth is the first event in atherosclerotic lesion formation, data have shown

that atherosclerotic lesions are localized to the sites of smooth muscle cell proliferation

where the cells facilitate lesion formation by producing extracellular matrix and by
increasing their cell mass (Schwartz et al., 1986; Ross, 1986). It is also found that smooth

muscle cells accumulate lipid deposits, their matrix and macrophage within the plaque.
The finding of a growth factor in platelets that is able to stimulate cell proliferation and
is potentially present at sites of endothelial denudation in the injured vessel wall (Ross et

al., 1974; Ross, 1981) further emphasized the role of smooth muscle cell proliferation in
the genesis of atherosclerosis.
Since the late 1970s, percutaneous transluminal coronary angioplasty (PTCA) has

become a popular technique to restore blood flow through stenotic atherosclerotic
coronary arteries. However, about 30% to 50% of patients, who initially benefit from the

procedure, will develop narrowed arterial lumen within a few months due to pathological

repair (restenosis). It is now widely accepted that following angioplasty, deregulated
intimal smooth muscle cell growth (Jackson and Schwartz, 1992) is responsible for the
restenosis. Balloon catheter injury to rat artery serves to strip away the endothelial lining

and damage the underlying smooth muscle layer. Within 4 days, there is major smooth
muscle cell proliferation in the injured media (Clowes and Schwartz, 1985; Clowes et al.,

1989). Smooth muscle cells migrate to the intima and proliferate. There is also an
increased synthesis and accumulation of extracellular matrix by intimal smooth muscle
5
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cells. These processes result in restenosis since even low levels of sustained replication

are sufficient to make a significant contribution to the vessel wall.
In recent years two concepts have been developed for the understanding of various

cardiovascular diseases: “endothelial dysfunction” and “arterial remodeling”. These two

processes are not independent. Dysfunctions of the endothelium are proposed to occur in
response to either pathological stimuli or genetic abnormalities, leading to the active

detrimental remodeling of the arterial vessel. This can initiate a vicious cycle causing the
development of diseases such as hypertension and atherosclerosis. Consistent with these

concepts, both endothelial abnormality and smooth muscle proliferation have been found
in essential hypertension and are thought to be responsible for the altered arterial
vasodilation and decreased lumen/media ratio respectively (Dzau and Gibbons, 1991).
Deregulation of smooth muscle cells is the major event following endothelial dysfunction,

leading to both short-term changes of vascular tone and long-term changes of vascular
structure (remodeling). In hypertension, the endothelium is functionally abnormal

(Luscher et al., 1987; Harrison et al., 1991; Panza et al., 1991) and could be a major cause
of arterial remodeling. Decreased internal diameter and increased wall thickness at the
level of small arteries, explained by the hypertrophy and/or hyperplasia of the medial

smooth muscle cells, may represent the remodeling process (Baumbach and Heistad,
1989; Mulvany, 1993; Heagerty et al., 1993). In atherosclerosis, chronic endothelial

damage could be caused either by mechanical trauma, hypercholesterolemia, immune
responses or viral injury. In response to the injury, smooth muscle cells migrate from the
6
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media to the intima where they synthesize and secrete extracellular matrix (Ip et al., 1990).
This chronic process will finally form plaques in the damaged area, changing the structure

of the diseased vessel. In the early stage of atherosclerosis, the artery enlarges in parallel
with plaque formation to preserve the surface area of the lumen. This compensatory

enlargement of the atherosclerotic artery delays stenosis of the lumen until the lesion

becomes moderately advanced. Active remodeling of the vessel wall also takes place
while the plaque accumulation leads to a gradual, progressive reduction in the arterial
i

lumen until decreased blood flow causes the appearance of clinical symptoms. When

angioplasty is used to restore the blood flow, patients immediately benefit from the

enlarged lumen created by the balloon catheter. But in 30 to 50% of the cases, a

pathological repair of the balloon damaged area will narrow the lumen again. This process
of restenosis is manifested as endothelial denudation, followed by the proliferation of

smooth muscle cells with the deposit of abundant extracellular matrix (Hamon et al.,
1995), representing an active process of pathological remodeling.

Hence it is now widely accepted that endothelial dysfunction and the

accompanying arterial remodeling are responsible for the pathogenesis of most
cardiovascular disease. While endothelial dysfunction might represent the initiating factor

of the pathology, arterial remodeling and deregulated smooth muscle cell proliferation are
the direct result responsible for these diseases. Thus, it is not surprising that there is

presently intense interest in the interaction of endothelial and vascular smooth muscle

cells, as well as the mechanisms that regulate smooth muscle cell proliferation.
7
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2. Plasticity of Smooth Muscle Cell Phenotype

Smooth muscle cells are derived embryonically from mesenchymal precursors and
migrate to their location during angiogenesis. During the early growth period, smooth

muscle cells actively divide and secrete a large amount of extracellular matrix proteins in

order to form new vessels. In the adult animal, the function of smooth muscle cells

changes from angiogenesis to the control of vascular tone. In order to perform this new
function, the cells lose their ability to migrate, proliferate and secrete as they differentiate
into competent contractile cells (Kocher et al. 1985). Differentiated smooth muscle cells

show a well-coordinated expression of proteins to perform this specialized function.

These proteins include contractile proteins (e.g. actin, myosin), membrane receptors, ion
channels, and signal transduction molecules. Smooth muscle cells can carry out several

functions depending on their developmental stage and the environment. Even in the adult
animal, they maintain the potential to proliferate and to synthesize and secrete proteins in

the event of damage and repair. The ability of the smooth muscle cell to perform these
different functions depends on its plasticity of phenotype. Indeed, this unique property of

the smooth muscle cell distinguishes it from other muscle cell types, such as skeletal and
cardiac muscle cells, which cannot dedifferentiate to an earlier developmental stage.

To facilitate the understanding of the smooth muscle cell, two phenotypes are
conventionally used to describe the different stage and function of these cells, the
“synthetic” and “contractile” phenotype. During angiogenesis or vessel repair after injuiy,

smooth muscle cells proliferate at a much accelerated rate and secrete more extracellular
8

matrix protein. This stage of smooth muscle cell is usually referred to as the “synthetic”

or “secretory” phenotype. In the healthy adult artery, smooth muscle cells proliferate at
an extremely low rate, secrete only a small amount of extracellular matrix proteins, and
express an array of proteins associated with contractile function. This stage of smooth
muscle cell is generally referred as the “contractile” phenotype. Since the smooth muscle
cells can exist in a continuum from the fully differentiated “contractile” phenotype to the
“synthetic” phenotype, it has been suggested that modulation may represent a better term

than dedifferentiation to indicate this range of changes in phenotype (Chamley-Campbell,

1981).
The intracellular structure and biochemical status of smooth muscle cells correlate
well with their requirement of function. In the synthetic phenotype, smooth muscle cells
have fibroblast-like shapes. They are rich in rough endoplasmic reticulum and Golgi

apparatus that are responsible for their greater secretory capability (Thyberg et al., 1983).

In the contractile phenotype, they are spindle-shaped for optimal stress-bearing function
and are filled with myofibrils composed of actin and myosin filaments. Actin is one of the
most important proteins in smooth muscle cell contractile performance. Mature fully
differentiated smooth muscle cells express four actin isoforms including smooth muscle

specific a-actin, nonmuscle P-actin, nonmuscle y-actin, and smooth muscle y-actin
(Gabbiani et al., 1984; Owens et al., 1986). The most abundant actin isoform in the
mature smooth muscle cell is smooth muscle specific a-actin, comprising 70% of the total
actin (Fatigati and Murphy, 1984). The contractile cell’s ability to develop tension
9

depends on the actin myofilaments being firmly attached to the cell membrane at
microscopically opaque focal points called dense plaques or dense bodies. The

cytoskeletal intermediate filament protein desmin is concentrated at the dense bodies

distributed between the myofilaments and in the many focal contact points along the
plasma membrane. There are two other specialized proteins, the actin-associated protein
a-actinin and the nonintegral membrane protein vinculin, which appear to act in this
binding complex (Glukhova et al., 1988). Together with other proteins in smooth muscle

cells, such as integrins, ion channels and receptors, these proteins are expressed in a well

balanced and coordinated manner, so that the smooth muscle cells can respond to a variety

of different stimuli by either contraction or relaxation.

Modulation of smooth muscle cell phenotype can be triggered by various events.
For example, in the presence of vascular injury, the contractile smooth muscle cells will

change their phenotype, and begin to proliferate and synthesize extracellular matrix
proteins to repair the damage. A great body of information regarding the phenotypic

modulation has been obtained from smooth muscle cell culture studies. In tissue culture,
smooth muscle cells undergo dramatic changes in structure and biochemistry. The
myofibrils disaggregate into monomers as the volume fraction of myofilments rapidly

falls. Rough endoplasmic reticulum enucleate from the nuclear envelope and spreads
throughout the cytoplasm, while stacks of Golgi cistemae develop near the nucleus

(Thyberg et al., 1983). As the contractile structures are replaced by synthetic organelles,
intracellular protein composition also changes dramatically. There is a dramatic change
10
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of actin isoforms with a shift toward expression of mainly noncontractile actin isoforms

(P and y-actin) (Barja et al., 1986). Other proteins involved in contraction, including
myosin heavy chain, caldesmin, calponin, and other regulatory proteins, are progressively

lost (Rovner et al., 1986; Ueki et al., 1987; Gimona et al., 1990). Proteins that are
indirectly involved in contraction, such as integrin, desmin, and vinculin, are also

downregulated (Belkin et al., 1988; Belkin et al., 1990; Orlandi et al., 1994). Cytoskeletal
desmin filaments are lost and replaced by another intermediate filament protein, vimentin

(Thyberg et al., 1990). These intracellular changes in cytoskeleton and membrane proteins
are accompanied by a dramatic change in the shape of the cell. The stress-bearing

elongated shape is lost as the cell starts to resemble the fibroblast. The decreased
expression of contraction-related proteins occurring in the adult smooth muscle cells

suggests that the phenotypic changes represent a dedifferentiation of the vascular smooth

muscle cell to a less specialized cell type.
The mechanism(s) governing smooth muscle cell differentiation and de

differentiation (phenotypic switch) is still under intense investigation. The ready alteration

of the phenotypic state of smooth muscle cells indicates the existence of in vivo
mechanisms for maintaining the contractile phenotype under normal conditions and
switching to the secretory phenotype when necessary. DeMey et al. (1989) showed that

arterial segments cultured in media supplemented with fetal bovine serum retained only

partial ability to contract for up to 3 weeks, indicating the potential role of humoral
influence on phenotypic changes. Mangiarua et al. (1992) employed pulsatile perfusion
11

of aortic segments to preserve their histology and function, suggesting an effect of
mechanical stimulation in maintaining the contractile phenotype. Interactions between

platelets and the blood vessel wall have demonstrated that potent growth factors, such as

PDGF, can play a major role in inducing phenotypic changes (Ross, 1986). A large
number of growth factors have been shown to affect the smooth muscle cell phenotype
through cell/cell interaction. These regulators include fibroblast growth factors (Risau et
al., 1988), insulin-like growth factors (Hansson et al., 1987), interleukin-1 (Libby et al.,

1988), and transforming growth factor (Antonelli-Orlidge et al., 1989). Thus, humoral

factors, mechanical stimulation, extracellular matrix interactions, and cell-cell interactions
have been suggested as in vivo factors likely contributing to the regulation of phenotypic
switching in smooth muscle cells.

3. Interactions Between Endothelial Cells and Smooth Muscle Cells

Endothelial cells play a role in many aspects of normal animal biology and it is
thought that most major cardiovascular diseases are associated with pathophysiological

alterations in endothelial cell structure and function. The endothelium acts as a selective

permeability barrier which controls the transport of water and solutes in the capillary,

regulates plasma lipids, participates in inflammatory and immune responses, maintains
the fluidity of the blood, and adjusts the caliber of blood vessels in response to the
environment.

The vascular endothelium performs these functions primarily by sensing changes

12

1

in its environment. A variety of stimuli, including hemodynamic (physical) forces,

circulating or locally produced humoral factors (vasoactive substances), and mediators
released from blood cells and platelets, can trigger endothelial cells to produce a host of
biologically active substances. These released substances, including small lipid and
protein molecules can, in turn, influence vascular tone and structure.

It has long been noticed that endothelial cells can release factors that regulate
vascular tone (Table 1). Prostacyclin (PGI2) was the first of these factors to be described
(Moncada et al., 1976). The vasodilator actions of PGI2 were found to be mediated by the

stimulation of an adenylate cyclase in vascular smooth muscle. In the intact endothelium,

PGI2 increases cyclic AMP levels, an effect that might decrease the proliferation and
permeability of the endothelial lining (Ito et al., 1980). In 1980, Furchgott and Zawadzki

reported that the relaxation evoked by acetylcholine in the aorta and other arteries of the
rabbit depend on the presence of endothelial cells. They described a labile vasodilator

with a very short half-life and named it endothelium-derived relaxing factor (EDRF).
EDRF is now known to be a potent vasodilator and inhibitor of platelet interaction with

the vessel wall. The effects of EDRF on smooth muscle cells are mediated through
activation of guanylate cyclase and an increase in intracellular levels of cGMP (Pelc et al.,

1987).

It was observed that the scavenger of superoxide anions (O 2-), superoxide

dismutase (SOD), markedly stabilizes EDRF released by acetylcholine from the canine

femoral artery (Rubanyi and Vanhoutte, 1986). The fact that superoxide dismutase
prolongs the half-life of EDRF indicated that the oxygen-derived free radical superoxide

13
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Table 1. Endothelium released vasoactive substances

3

Relaxing Substances

Endothelium-derived relaxing
factor (NO)

Furchgott and Zawadzki, 1980; Palmer et
al., 1987; Ignarro et al., 1987

Endothelium-dependent
hyperpolarizing factor (EDHF)

Feletous and Vanhoutte, 1988; Tare et al.,
1990; Standen et al., 1989

Prostacyclin

Luscher and Vanhoutte, 1990;
Moncada and Vane, 1979

Prostaglandin £2

Busse et al., 1984

Adenosine

Bardenheuer et al., 1987; Kroll et al., 1987

Contracting Substances

Endothelin

Yanagisawa et al., 1988; Kasuya et al., 1989

Angiotension II*

Ng and Vane, 1967; Saye et al., 1984

Histamine

DeForrest and Jollis, 1978;
Hollis and Rosen, 1972

Thromboxane A2

Yang et al., 1991; Vanhoutte et al., 1985

Free radicals (O2“, OH“)

Katusic et al., 1989;
Rubanyi and Vanhoutte, 1988

* Angiotensin II is converted from angiotensin I by endothelial cells.
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anion rapidly inactivates the mediator (Gryglewski et al., 1986). This led to the proposal

by Furchgott (Khan and Furchgott, 1987) and Ignarro (1987) that EDRF may be the
radical nitric oxide (NO). Other factors, such as endothelium-dependent hyperpolarizing

factor (EDHF) (Feletous and Vanhoutte, 1988) and adenosine (Bardendeuer et al., 1987),

have also been reported to be released by endothelium and cause relaxation effects on
smooth muscle cells.
Endothelial cells are also capable of releasing contracting factors. In 1988,

Yanagisawa et al. described a peptide that may mask or attenuate acetylcholine-induced
EDRF release and vasodilation, depending on the dose and the state of the endothelium.
This peptide contains 21 amino acids and is named endothelin (Masaki, 1989). It is

!

Il

claimed to be the most potent mammalian vasoconstrictor peptide known to date

(Yanagisawa et al., 1988). In the picomolar to nanomolar range, endothelin was found
to be able to induce concentration-dependent contractions in various arteries, including

arteries from pig, dog, man (Yanagisawa et al., 1988), and rat (Rodman et al., 1989).
Endothelin is generated from the precursor molecules preproendothelin and proendothelin

and converted by a putative endothelin-converting enzyme for the expression of the full

vascular activity (Kimura et al., 1989). The existence of specific binding receptors for
endothelin in vascular smooth muscle cells has been demonstrated (Hirata et al., 1988).

Binding of endothelin receptors is associated with activation of phospholipase C and
subsequent stimulation of phosphoinositide turnover, suggesting the existence of a
specific receptor-phospholipase system (Lin et al., 1989). Endothelin also evokes a rapid
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and transient increase in cytosolic Ca++. The rapid increases in inositol triphosphate and
cytosolic Ca++ might be responsible for the contractile response in smooth muscle cells

(Wallnofer et al., 1989). Other contractile factors released by the endothelium include

histamine (DeForrest et al., 1978) and thromboxane A2 (Yang et al., 1991). Free radicals
such as superoxide anion are also released by endothelial cells (Katusic et al., 1989) and

probably increase vascular tension by inactivating the nitric oxide released by endothelial
cells themselves.

These data indicate that the endothelium plays a crucial role in the regulation of

vascular tone through the release of vasoconstricting or vasorelaxing factors in response
to a variety of stimuli. At basal conditions, these opposing factors achieve a state of

equilibrium and normal vascular tone is maintained. Alterations in hemodynamic
conditions or humoral factors may result in an imbalance of these modulating factors,
thereby favoring vasoconstriction or vasodilation. Due to the close anatomic relationship
between the endothelium and smooth muscle cell, the endothelial regulation of vascular

tone may be the most efficient and rapid way of achieving appropriate vascular tone.

1
However, the regulation of vascular tone is a relatively short-term adaptation. The

J

long-term adaptive responses to the sustained alterations in hemodynamic conditions or

humoral factors are mediated primarily by changes in vascular structure, the so-called
“remodeling”. The endothelium actively participates in this process by releasing a group

of factors controlling cell growth or regression as well as extracellular matrix expansion
16
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or contraction in the vessel wall. Again, due to its anatomical advantages, endothelial

regulation of smooth muscle cell growth or repression is an efficient and potent regulatory

method compared to other kind of regulatory mechanisms.
Endothelial cells can participate directly in vascular remodeling by the release or

In
-

activation of substances that can influence the growth and migration of cellular elements
or through alterations in the status of the extracellular matrix. A variety of growth factors

that either inhibit or promote smooth muscle proliferation have been identified (Table 2).
The first mitogen to be studied extensively for effects on smooth muscle cells was a
polypeptide found in platelets (Ross, 1986), the platelet-derived growth factor (PDGF),

which later was also found to be expressed and released by endothelial cells (Starksen et
al., 1987). There are many PDGF isoforms and numerous different receptors for PDGF

have been identified (Cercek et al., 1991). PDGF can exert a mitogenic effect on smooth
muscle cells. After binding to its receptor, PDGF stimulates autophosphorylation of the

receptor and activates protein kinase C (PKC) (Inui, et al., 1994), tyrosine kinase, and

serine/threonine kinases (Williams, 1989). PDGF has been termed a “competence” factor

in that it makes cells competent to enter the cell cycle, moving the cell from the arrested
state (Go) to active cell cycling (GJ (Pardee, 1989). PDGF-stimulated cells require a

second group of growth factors, termed “progression factors”, to enter the S phase and

initiate DNA synthesis and cell division (Pardee, 1989). Among these progression factors,
epidermal growth factor (EGF) and insulin-like growth factors type 1 (IGF-1) may be

important in intimal control of proliferation of smooth muscle cells (Banskota et al., 1989).
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Table 2. Endothelium-Derived Growth Factors

Growth promoting substances

Platelet derived growth factor
(PDGF)

Starksen et al., 1987

Acidic fibroblast growth factors
(aFGF)

Risau et al., 1988

Basic fibroblast growth factors
(bFGF)

Saksela and Rifkin, 1990

Insulin-like growth factor-I

Hansson et al., 1987

Interleukin 1 (IL-1)

Libby et al., 1988

Angiotensin II*

Naftilin et al., 1989; Bobik et al., 1990

Endothelin

Dubin et al., 1989; Nakaki et al., 1989;
Komuro et al., 1988; Bobik et al., 1990

Thromboxane A2

Dorn et al., 1992

Growth inhibitory substances

Endothelium-derived relaxing factor
(NO)

Garg and Hassid, 1989
Kariya et al., 1989

Prostacyclin and Prostaglandin E

Nilsson and Olsson, 1984

Transforming growth factor-P

Antonelli-Orlidge et al., 1989
Sato et al., 1990

Heparin sulfate

Castellot et al., 1982;
Majack and Clowes, 1984

Adenosine

Bardenheuer et al., 1987;
Jonzon et al., 1985

* Angiotensin II is converted from angiotensin I by endothelial cells.

18

I

The endothelium is fully capable of synthesizing and releasing these progression factors

(Hansson et al., 1987). Endothelial cells also produce other growth factors, including b-

FGF (basic fibroblast growth factors) (Saksela et al., 1988), and an angiogenic factor with
proliferative properties for both smooth muscle cells and endothelial cells (Lindner et al.,

1990). Injection of antibodies against b-FGF limits the first cycle of smooth muscle cell

replication in the arterial media by up to 80% following balloon denudation. This
observation further supports the suggested proliferative effects of this growth factor

(Lindner and Reidy, 1991).

Vasoconstricting substances are also involved in the regulation of vascular smooth

muscle cell proliferation. Local generation and receptor binding of angiotensin II have
been found within the arterial wall (Dzau, 1984). Endothelial synthesis and conversion

of angiotensin has been demonstrated by other researchers (Naftilan et al., 1989; Bobik
et al., 1990). There is evidence that angiotensin II may modulate smooth muscle cell

growth in vitro and in vivo and this property of angiotensin II is mediated, in part, by

induction of nuclear proto-oncogenes (Moalic et al., 1989; Taubman, et al., 1989; Berk
et al., 1989), or by influencing nutrient uptake (McCumbee et al., 1995). Considerable

interest has also been focused on endothelin, another potent vasoconstrictor peptide

produced by endothelial cells. Endothelin binds specifically to human smooth muscle cells
in culture and can induce nuclear oncogene expression (Clozel et al., 1989; Komuro et

al., 1988). Endothelin has also been shown to have effects on mitogenic activity (Komuro
et al., 1988) of rat aortic smooth muscle cells. Endothelin is, therefore, another example
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of a substance besides angiotensin II with the dual function of stimulating vascular

smooth muscle cells in a contractile phenotype to contract and cells in a synthetic
phenotype to divide.
Smooth muscle cells in normal adult arteries show essentially no replication

i

(Clowes et al., 1989) and even in advanced atherosclerotic lesions, the level of smooth

muscle replication is quite low (Gordon et al., 1990). The predominant effect of the
endothelial cell layer on smooth muscle cell growth in vivo is clearly inhibition. For
example, balloon catheter denudation of vessels in situ leads to hyperplasia of the
underlying smooth muscle cells in which there is neointimal thickening and the display

of characteristics consistent with a dedifferentiated "synthetic" phenotype by the
proliferating cells (Fisherman et al., 1975). The smooth muscle cell growth is greatest as

the endothelial layer is growing to cover the injured vessel and indices of smooth muscle
cell proliferation drop dramatically when endothelial cell confluence is reached (Koo and

1

Gotlieb, 1991). In vitro studies on the interactions of endothelial cells and smooth muscle
cells also support this notion (Dodge et al., 1993; Wang et al., 1997b). For example,

subconfluent proliferating endothelial cells stimulate the growth of smooth muscle cells
(Dodge et al., 1993), whereas postconfluent endothelial cells inhibit smooth muscle cell

growth (Wang et al., 1997b). The inhibitory effect of endothelial cells is achieved mainly
through its release of a group of inhibitory factors (Table 2).

As early as 1974, Nam et al. showed that an aqueous extract of pig aorta injected

intaperitoneally into swine reduced the rate of entry of arterial smooth muscle cells into
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mitosis. Eisenstein et al. reported in 1979 that sulfated polyanions, including heparins and

proteoglycans, inhibited the growth of both smooth muscle and endothelial cells. Clowes
and Kamovsky (1977) and Majesky et al. (1987) further discovered that exogenous
heparin could inhibit proliferation of smooth muscle cells in response to removal of the
endothelium with a balloon catheter. In 1981, Castellot et al. found that endothelium and

smooth muscle cell synthesize heparin sulfates capable of inhibiting smooth muscle

growth.

It has been proposed that following endothelial denudation, platelets are

deposited on the subendothelium releasing heparitinase and PDGF, resulting in the

breakdown of heparin sulfate and initiation of smooth muscle growth (Castellot et al.,
1981). Studies suggest that the anti-proliferative effect of heparin may be related to an

inhibitory effect on proto-oncogene expression (Wright et al., 1989) or that it prevents cell
entry into the S phase of the cell cycle, without any inhibitory effect on early proto

oncogene expression (Reilly et al., 1989).
Recently EDRF has also been shown to be a potent inhibitor of smooth muscle cell

proliferation (Assender et al., 1991). EDRF stimulates soluble guanylate cyclase and

increases cyclic GMP levels in smooth muscle cells (Furchgott and Vanhoutte, 1989). The
finding that the nitric oxide-generating drug sodium nitroprusside and the cGMP analog

8-bromo-cGMP effectively inhibited DNA synthesis and proliferation of rat aortic smooth

muscle cells in culture further supports the assumption of NO’s inhibitory effects on cell
growth (Carg and Hassid, 1989). Other vasodilators released by the endothelium, such as

prostacyclin, prostaglandin £2, and adenosine, activate adenylate cyclase and exert
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inhibitory effects on smooth muscle cell proliferation (Jonzon et al., 1985; Nilsson and

Olsson, 1984).

Endothelial cells also make and secrete TGF-P (Antonelli-Orlidge, et al., 1989).
In vitro experiments have shown TGF-P to be bifunctional; while it inhibits PDGFstimulated growth of smooth muscle cells in subconfluent monolayers, it promotes growth

after maximum cell-cell contact, allowing the smooth muscle cell to grow over one

i

another, giving a “hill and valley” appearance to the culture (Majack, 1987). In fact, TGF-

P inhibits subconfluent smooth muscle cell growth in response to any competence factor
(Morisaki etal., 1991). During the early stages of smooth muscle cell proliferation, TGF-P

appears to be anti-proliferative, down-regulating smooth muscle cell PDGF receptors

(Hahn et al., 1991); whereas, later in the development of fibrous plaque, TGF-p induces
smooth muscle cell PDGF mRNA (Raines et al., 1989).

In summary, the endothelial cells sense changes in its environment and releases
a group of factors in response to these changes. For short- term regulation, these factors
change the contractile response of smooth muscle cells, thereby, adjusting the caliber of

the vessel wall. For long-term regulation, factors released by endothelial cells either

promote or inhibit the growth of smooth muscle cells. Under normal conditions, the
opposing forces achieve a state of equilibrium and homeostasis is maintained. Under

pathological conditions, the secretion pattern of various factors may become unbalanced,
leading to malfunction of vessel contraction or maladaptive changes of vessel wall

thickness, contributing to the pathogenesis of cardiovascular diseases such as
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atherosclerosis, hypertension, and restenosis after PTCA.

4. Retinoid Family and Its Effects in Vasculature

Retinoids are essential for vision, reproduction, growth and differentiation, and

maintenance ofthe general health of the organism (Goodman, 1984b). The retinoid family

contains the alcohol (retinol), the aldehyde (retinal), the acid (retinoic acid) as well as
other synthetic and semi-synthetic forms. Dietary retinoid, either as preformed retinol or

II

provitamin A (carotenoids), is taken up in the intestine and packaged as retinyl ester,

along with other lipids, in chylomicrons (Blomhoff et al., 1990). The majority of this

retinyl ester is delivered to the liver. The retinyl ester is either stored in liver or secreted
from liver in the form of retinol. Secreted retinol in association with plasma retinol

binding protein (RBP) circulates to peripheral tissues as the retinol-RBP-transthyretin

i

complex (Blomhoff et al., 1991). The concentration of plasma retinol is tightly controlled
over a wide range of adequate liver vitamin A reserves. Retinol is maintained in plasma

at approximately lO^M in humans (Wahrendorf et al., 1986) and other animals (Rogers

I

et al., 1993; Hendriks, 1988), while retinoic acid is kept at a relatively low level (10‘9M)

in humans (Cullum and Zile, 1985; Napoli et al., 1985) and in rats (de Leenher et al.,
1982; Eckhoff and Nau, 1990). Kinetic studies have demonstrated that the retinol

molecule cycles several times between liver and extrahepatic tissues before it is degraded
(Blomhoff et al., 1991). Retinol enters the cytoplasm of peripheral tissue either through

direct diffusion after dissociation from RBP (Noy and Blaner, 1991; Creek et al., 1993),
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or through receptor-mediated uptake (Anonymous, 1991; Bavik et al., 1991). The

internalization of retinol by cells may also involve the actions of cellular retinol binding

protein (CRBP) (Noy and Blaner, 1991). Within the cell, the retinol can be metabolized
to retinyl ester or oxidized to retinoic acid, a process which has been proposed to involve

CRBP (Posch et al., 1991). It is generally assumed, based on the relatively high levels of

retinol in tissues and plasma and the abundant enzymes in tissues which are able to

J

oxidize retinol to retinoic acid, that the in situ oxidation of retinol to retinoic acid is the
major route for production of cellular retinoic acid (Blomhoff et al., 1990).
Retinoic acid is now recognized as a major physiologically active metabolite of

retinol (Napoli et al., 1991). Retinoic acid and possibly some of its metabolites are the

active forms responsible for mediating most of the nonvisual functions of this class of
compounds. Both 9-cis and all-trans retinoic acid interact in the nucleus with ligand

dependent transcription factors to regulate expression of retinoid responsive genes. Two
distinct classes of nuclear receptors for retinoic acid have been described, including the
retinoic acid receptors (RARa, P, y) and the retinoid X receptors (RXRa, P, y) (Chambon,

1996). The RAR family is activated both by all-trans and 9-cis retinoic acid, whereas the

RXR family is activated exclusively by 9-cis retinoic acid (Chambon, 1994). Response
elements for these transcription factors have been characterized for a diverse group of

genes including those for RARp, cellular retinol binding protein type I (CRBP-1),
apolipoprotein A-I, and oxytocin. Retinoids regulate the expression of nearly 150 genes

(Chytil and Riaz-ul-Haq, 1990).
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In general, retinoids such as all-trans retinoic acid inhibit cell proliferation and
promote differentiation (Blomhoff, 1994), and this has been further proved by genetic
inactivation of retinoid receptors in mice (Chambon, 1994; Chytil and Riaz-uI-Haq,

1990). This property of retinoids has been extensively applied in the field of oncology and
dermatology. For instance, acute promyelocytic leukemia has been successfully treated
with all-trans-retinoic acid (Warrell et al., 1993); certain skin and head and neck cancers
have been relieved by 13-cis retinoic acid (Lippman et al., 1995); and retinoic acid and

some of its synthetic chemical derivatives have exhibited therapeutic benefits in a series
of dermatological conditions such as acne, psoriasis, and other keratinizing disorders
(Blomhoff, 1994). Due to its physiological action, namely as a circulating compound that

activates gene expression, Vitamin A can be regarded as a hormone, similar to the steroid
hormone and the thyroid hormone (Sporn and Roberts, 1983). As stated by Wolf et al.

(1970), “It is quite conceivable that a hormone can be taken in the diet, stored in the liver,
and secreted into the blood stream when needed. The liver then acts as the endocrine

organ”.

The potential importance of the effect of retinoids on the cardiovascular system has

only recently become apparent. Heine et al. (1985) reported that chicken embryos made
deficient for vitamin A have a grossly underdeveloped circulatory systems. Retinoic acid

has subsequently been shown to induce the expression of smooth muscle characteristics

in a clonal cell line derived from multipotential embryonal carcinoma cells (Blank et al.,
1995). Retinoic acid treatment also induced expression of alpha? integrin in the
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multipotential P19 mouse embryonic stem cell line and changed the morphology to that
resembling differentiated vascular smooth muscle cells (Yao et al., 1997). Drab et al.

(1997) treated totipotent mouse embryonic stem cells with retinoic acid and observed the
induced differentiation of spontaneously contracting cell clusters. These spontaneously

contracting cells express myosin heavy chain and typical ion channels and have functional
vascular smooth muscle cell properties. Retinoic acid also induced the expression of

smooth muscle myosin heavy chain isoform in developing ductus arteriosus and promoted
precocious expression of the adult vascular smooth muscle phenotype in embryonic and
fetal development (Colbert et al., 1996). These data indicate the essential role of retinoic

acid in the regulation of early smooth muscle development and differentiation. The
demonstration that all-trans retinoic acid is able to preserve the contractile competence of
rat aortic rings in culture further suggests a possible physiological role of retinoids in

maintaining smooth muscle cell differentiation in the adult animals (Wright et al., 1996).
Vascular smooth muscle cells express five of the retinoid receptors, namely RAR-

a, -p, -y and RXR -a, -P (Miano et al., 1996). Retinoic acid binds to retinoid receptors and
activates the expression of target genes such as RAR-p in smooth muscle cells (Miano et

al., 1996). All-trans retinoic acid causes dose-dependent growth inhibition of cultured
vascular smooth muscle cells with upregulation of the expression of elastin, smooth
muscle specific a-actin, desmin, and integrin (Hayashi et al., 1995; Haller et al., 1995).

In summary, retinoic acid enhances contractile competence (Wright et al., 1996), induces
differentiation, and exerts anti-proliferative effects on smooth muscle cells. These effects
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may be mediated by its activation of the protein kinase C pathway (Wright et al., 1996;

Haller et al., 1995), inhibition of AP-1 activity (Miano et al., 1996), or stimulation of

ADP-ribosyl cyclase activity (de Toledo et al., 1997).
The functions of nonnuclear retinoic acid receptors are still unknown. Evidence
is accumulating that they determine the cell’s capacity for retinol accumulation by

regulating retinol uptake (Creek et al., 1993) or that they may have an important role in
retinol esterification (Herr and Ong, 1992) and in the production of retinoic acid (Napoli,

1993). Smooth muscle cells in culture fail to respond to high doses of retinol (Hayashi
et al., 1995; Wang et al., 1997b), suggesting a possible inefficiency in metabolizing

retinol to its active metabolites. In addition, it has been reported that smooth muscle cells
from newborn and aged rats exhibits a differential expression of proteins with CRBP

expressed in smooth muscle cells cultured from aged but not newborn rats (Cremona et
al., 1995). CRBP was also observed to be present in smooth muscle cells isolated from

intimal thickenings 15 days after an endothelial lesion but not in the normal adult cell

(Neuville et al., 1997). It has been also shown that CRBP expression appears transiently
in the smooth muscle cells after endothelium injury and disappears when re-

endothelialization takes place (Neuville et al., 1997). It is further noteworthy that smooth
muscle cells cultured from aged rats or intimal thickening possess relatively low amounts

of a-smooth muscle actin and desmin, have a highly dedifferentiated phenotype, and
exhibit an epithelioid-like appearance (Bochaton-Piallat, et al., 1993; Bochaton-Piallat,

et al., 1996). Treating these cells with retinoic acid but not with retinol resulted in the
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appearance of spindle-shaped morphology, resembling the more differentiated VSMC
phenotype (Neuville et al., 1997). This morphology change coincides with the induction
of CRBP expression by retinoic acid (Neuville et al., 1997). Therefore, it appears that

there is a reverse relationship between the differentiated state and the expression of
CRBP. As one explanation for the response to endothelial injury, smooth muscle cells
begin to proliferate and, in the meanwhile, they are prepared to respond to retinol by

expressing CRBP. Pathological repair is subsequently terminated with apoptosis. The
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exact function of CRBP in smooth muscle cells still remains largely unknown, and studies

are still needed to clarify the role of CRBP and retinoids in smooth muscle cell activation

and phenotype modulation.
Retinoids exert significant influences not only on smooth muscle cells but also on
■ :'i

endothelial cells in the cardiovascular system. As mentioned earlier, retinol is maintained
at high concentrations in plasma (Wahrendorf et al., 1986), and the endothelium is

chronically exposed to retinol and other retinoids. The functions of the endothelium are

modified by retinoids in many ways. For example, one of the endothelial functions is to
regulate the deposition of fibrin in the vascular system. Tissue type plasminogen activator

(t-PA) is considered to play an important role in the onset of the fibrinolytic activity
through conversion of the zymogen plasminogen into the active enzyme plasmin which

can degrade fibrin (Wun and Capuano, 1985). Therefore, the fibrinolytic capacity of
plasma is considered to be strongly dependent on circulating t-PA concentrations. Plasma
t-PA is presumed to be mainly derived from the vascular wall, where it is localized in the
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endothelial cells (Emeis, 1988). Retinoic acid and other retinoids specifically stimulate

the production of t-PA in cultured human vascular endothelial cells (Kooistra, 1991) and
downregulate the expression of plasminogen activator inhibitor in bovine endothelial cells
(Kojima et al., 1993), enhancing the fibrinolytic activity of endothelial cells. Endothelial

cells also have antithrombotic properties due to production of thrombomodulin (protein

C and protein S), which acts to prevent the process of coagulation. Retinoic acid treatment
increases the expression of thrombomodulin on the surface of cultured human endothelial
cells (Horie et al., 1992), and can counteract the downregulation of thrombomodulin

caused by inflammatory cytokines such as tumor necrosis factor (Ishii et al., 1992). These

data suggest that retinoids may participate in physiologic regulation of the hemostatic

balance at the endothelial cell surface. This benefit has been evidenced by the correction
of disseminated intravascular coagulation (DIC) with retinoic acid treatment in leukemia

patients (Castaigne et al., 1990).
Retinoids also influence the growth factor releasing pattern of endothelial cells.
The endothelium is capable of production and release of tissue transforming growth
factor-|3 (TGF-P) (Antonelli-Orlidge et al., 1989). TGF-P is a potent growth inhibitor of
endothelial (Baird and Durkin, 1986) and smooth muscle cells (D’Amore and Smith,

1993). TGF-P increases the production of cell matrix components such as collagen and
fibronectin (Werwin et al., 1990) and decreases metalloproteinase activities by both the

suppression of metalloproteinase production and the enhancement of the production of

a tissue inhibitor of metalloproteinases (Overall et al., 1989). TGF-P is synthesized and
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secreted by endothelial cells in a biologically latent form that must be activated before it
can bind to its receptors and exert its biological activities (Hannan et al., 1988). Activation

of latent TGF-p can occur in co-culture of endothelial cells with smooth muscle cells
(Antonelli-Orlidge et al., 1989; Sato et al., 1990). Retinoids enhance the production of

plasminogen activator, a putative physiological activator of latent TGF-P and, thereby
increase the active forms of TGF-P (Kojima and Rifkin, 1993). After treatment with
retinoids, endothelial cells also express increased levels of transglutaminase with the

generation of TGF-P, whereas smooth muscle cells and fibroblasts do not activate latent
TGF-P after treatment with retinoids (Kojima et al., 1993). The change of endothelial

secreting pattern after retinol treatment is further suggested by the observation that
conditioned medium from retinol-treated endothelium has more inhibitory effects on
proliferating smooth muscle cells compared to conditioned medium from untreated

endothelium (Wang et al., 1997b).

Endothelial cells normally exhibit low turnover rates in the body (Hobson and
Denekamp, 1984). However, new blood vessel growth (angiogenesis) does occur during

wound healing and is a hallmark and serious complication of many disease states, such
as diabetic retinopathy and malignant tumor formation. Like smooth muscle cells, the
proliferation of endothelial cells also involves changes from one differentiation state to

another. When physiological doses of retinol are added to growing endothelial cells, this
causes a cessation of endothelial proliferation and promotes a change in the phenotype of

the cells in vitro (Braunhut and Palomares, 1991). Retinol-treated endothelial cells have
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a rounder cell body, increased refractivity at cell edges, and longer cytoplasmic processes
distributed in a bipolar fashion under subconfluent conditions (Braunhut and Palomares,

I

1991). In the presence of retinol, bovine aortic endothelial cells are flat in appearance and

form a monolayer at confluence as compared to endothelial cells cultured in the absence
of retinol which tend to have protrusions overlapping each other (Wang et al., 1997b).
Following treatment with retinol, endothelial cells exhibit increased adhesivity and are

rendered unresponsive to potent endothelial cell mitogens, such as fibroblast growth
factor (Braunhut and Palomares, 1991). The matrix of retinol treated cells contains
increased amounts of total protein when compared to control endothelial cell matrices
(Paige et al., 1991). Electron microscopic observations also showed that retinol-treated
!

aortic rings had a thicker sub-endothelial space as compared to control (Wang et al.,
1997b) further suggesting increased cell secretory activity.

Endothelial cells synthesize and deposit basement membrane component, such as

type IV collagen (Madri and Williams, 1983; Kramer et al., 1985), laminin (Madri and
Williams, 1983), and heparin sulfate proteoglycan (Kinsella and Wight, 1986). The
basement membrane serves as a selective permeability barrier to molecules, restricts

passage of cells, and can affect the growth and differentiation of cells. Endothelial cells
also secrete matrix-degrading enzymes such as metalloproteinase (Herron et al., 1986;
DeClerck and Laug, 1986), which degrade and remodel the basal membrane. Retinol and
retinoic acid treatment of endothelial cells differentially affects the types and activities of
matrix metalloproteinases and matrix metalloproteinase inhibitors, favoring the increase
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of extracellular matrix of endothelium and the growth inhibition of the cells (Braunhut

and Moses, 1994). Thus, the effects of retinoids in inhibiting endothelial and smooth
muscle cell growth may be explained by their ability to change growth factor release or

activation, whereas the changes of basal membrane composition may underscore the
morphological changes caused by retinoids.
Current data indicate that at least two forms of retinoids, retinol and retinoic acid,
can modify endothelial function. Retinol is the form of Vitamin A that endothelial cells

are exposed to in plasma, but it is not known how retinol is metabolized by endothelial
cells in vivo or in vitro. In most cell systems, retinoic acid is a more potent inhibitor of

growth or inducer of differentiation than retinol. However, there are a growing number

of examples of retinol exerting unique effects on cells that are distinct from those caused
by retinoic acids (Audette and Page, 1983; Rundhaug et al., 1987; Buck et al., 1991). No
nuclear receptors for retinol have been found and retinol’s action is therefore thought to

be mediated by its potential metabolites (Goodman, 1984a; Bucket al., 1991). Endothelial
cells express CRBP (Neuville et al., 1997) and cellular retinoic acid binding protein I

(CRABP-1) (Kooistra et al., 1995), which may play a role in channeling retinoid

metabolism and the delivery or sequestration of retinoids to or from the nuclear receptors.
RAR -a, -P, -y and RXR -a, -P have been shown in cultured human umbilical vein
endothelial cells (Kooistra et al., 1995). RARa is involved in retinoid induced t-PA

expression in endothelial cells, whereas the specific RARa antagonist, R^ 41-5253, is
able to suppress the induction of t-PA by retinol (Kooistra et al., 1995). It seems that
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endothelial cells possess all the enzymatic machinery to metabolize retinol, although

experiments are needed to demonstrate the functionality of these enzymes.
In summary, although relatively little information is available in this field, the
retinoid family is clearly important in modulating the function of the cardiovascular
system and may be a potentially powerful therapeutic weapon in the treatment of

cardiovascular diseases. Retinoic acid may be required to regulate early stem cell

commitment and smooth muscle cell development and to maintain smooth muscle cell
function and differentiation in adult animals. Smooth muscle cells respond to retinoic

acid, but fail to respond directly to retinol, the parent molecule of retinoids, indicating
their dependence on exogenous sources of retinoic acid. In contrast, both retinol and

retinoic acid can directly modify endothelial functions, such as antithrombotic activity,

basal membrane formation and remodeling, as well as growth factor release and
activation. An important area of future study would be to analyze retinol metabolism in
endothelial cells and identify, bioactive derivatives of retinol which may be responsible
for the observed changes in endothelial cells, or the changes in smooth muscle cells

caused indirectly by factors released by endothelial cells.

5. Protein Kinase C as a Signal Pathway in Smooth Muscle Cells

The activation of a signaling cascade by receptor-mediated generation of
intracellular second messengers is a common and versatile transduction mechanism
utilized for external stimuli such as hormones, neurotransmitters, growth factors, and
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drugs (agonists) that interact specifically with plasma membrane receptors. Protein kinase

C (PKC) is a well known example of one signal transduction mechanism that regulates
a variety of cellular functions, including cell proliferation and differentiation (Clemens et

al., 1992). Protein kinase C is a serine-threonine kinase that was first described by Inoue
et al. in 1977. Various data have ascribed a multiplicity of functions to PKC. Recurring

themes are that PKC is involved in receptor desensitization, in modulating membrane
structure events, in regulating transcription, in mediating immune responses, in regulating
cell growth, and in learning and memory, among many other functions (Nishizuka, 1995).
PKC consists of a family of closely related isoenzymes that differ in their structure,

cofactor requirement, and substrate specificity (Hug and Sarre, 1993; Azzi et al., 1992).

At present, the known mammalian protein kinase C family consists of at least 12 different
polypeptides: a, pi, pH, y, 5, e, £, rj, 0, i, X, p (Nishizuka, 1995). The protein kinase C

family has been subdivided into conventional, novel, and atypical groups. The

conventional protein kinase C enzymes, comprising protein kinase C a, pi, pH, and y, are
calcium-dependent enzymes that require di acylglycerol and membrane phospholipid
(usually phosphatidylserine) for activation. The novel protein kinase C enzymes,

comprising protein kinase C 5, e, q, 0 and p, also require diacylglycerol and membrane

phospholipid for activation, but are calcium-independent. The atypical protein kinase C
enzymes, comprising protein kinase C

i, and X, are not activated by diacylglycerol or

phorbol esters. The differential tissue expression of the various protein kinase C isoforms,

together with their subspecificity, may explain how a protein initially perceived to be a
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single ubiquitous enzyme has subsequently been shown to play a pivotal role in so many

biological functions.
The structure of a specific protein kinase C isoform determines its properties in
terms of regulation and responsiveness. The C-terminal region of protein kinase C

constitutes the catalytic domain and is identical in all the PKC isoenzymes, irrespective
of their calcium requirement. The N-terminal regions are identified as the regulatory
domain and, in fact, there are modifications of this domain among the various PKC

isoenzymes. The catalytic domain is separated from the regulatory domain by a hinge
region that is identified in all the isoenzymes. Adjacent to the hinge region toward the N-

terminal end lies the calcium binding domain in the a, pi, pH, and y isoenzymes only. All
the PKC isoenzymes with the single exception of £ subspecies contains two zinc fingers.
The £ isoenzyme contains a single zinc finger, is not activated by phorbol ester, and does
not require calcium as a cofactor (Newton, 1995).
External stimuli such as growth factors, hormones, and neurotransmitters activate

receptors located at the plasma membrane, which are tyrosine kinase-linked receptors or
G-protein-1 inked receptors. The stimulation of both receptors generates di acylglycerol and

inositol 1,4,5-trisphosphate (IP3) via the hydrolysis of inositol 4,5-bisphosphate (PIP2) by

specific C-type phospholipase (Rhee and Choi, 1992). IP3 mobilizes calcium from the
endoplasmic reticulum, which causes translocation of PKC to the plasma membrane for
activation by diacylglycerol. Several identified PKC-binding proteins may play a role in

targeting the activated PKC molecule to specific sites where the enzyme remains active

35

and can phosphorylate selective substrates. PKC frequently associates with proteins in

particulate fractions, which are probably cytoskeletal (Mochly-Rosen et al., 1990) as well

as nuclear proteins (Leach et al., 1989). This group of proteins, termed RACKs
(receptors of activated C-kinase), may act as receptors for the activated form of PKC and
serve to stabilize the active enzyme to a specific locus on the membrane (Liao et al.,

1994). Different PKC isozymes do not have a large degree of in vitro substrate specificity
(Kazanietz et al., 1993), which further suggests that subcellular localization and

translocation are essential for selective phosphorylation upon activation.

Phorbol ester is a compound resembling diacylglycerol. All isotypes except the

atypical ones bind biologically active phorbol esters and these poorly metabolized agents
can induce prolonged activation of PKC. The use of phorbol esters in various

experimental contexts has provided evidence for the potential for PKC isotypes to regulate
a plethora of biological events. One consequence of this long-lived activation is that
responsive PKC isotypes are degraded, a phenomenon that has been termed down
regulation. Studies in intact cells have demonstrated that on chronic exposure to phorbol

esters, the loss of steady-state PKC protein is due to a net increase in proteolysis without
a change in the rate of synthesis (Young et al., 1987). Trypsin or a calcium-dependent
neutral protease have been found to be responsible for proteolysis in the hinge region of

the PKC molecules (Pontremoli et al., 1988).
Deciphering the specific functions ofPKC isozymes is complicated by the multiple

expression and specific localization of different isoforms in a single cell type as well as

36

i

I

differential expression of isoforms in different cell types. As a result, stable expression of
PKC isoforms in different cell types is commonly used to evaluate specific isoform

function. For example, overexpression of PKCa in F9 teratocarcinoma cells decreased the
growth rate (Kindregan et al., 1994), but had the opposite effect in MCF-7 breast cancer
cells (Ways et al., 1995). Overexpression of PKCPj in murine keratinocyte 3PC cells
enhanced TPA-induced growth inhibition (O’Driscoll et al., 1994), overexpression of

PKC8 and PKCe in NIH3T3 cells increased cell density (Lehel et al., 1994), and the
overexpression of PKCa and pl in rat fibroblast cells had divergent growth effects, with

the former inhibiting and the latter enhancing cell growth (Borner et al., 1995),
respectively. Taken together, these data clearly show that the effects of PKC on growth

regulation is both isoform- and cell type-dependent. The need for caution in the
interpretation of overexpression data has been emphasized in recent studies suggesting

that high levels of a given PKC isotype may have effects which are independent of any
isotype-specific cellular role (Yamaguchi et al., 1995).

PKC has been implicated in the regulation of several areas of smooth muscle

physiology, ranging from regulation of phospholipid turnover and smooth muscle
contraction to modulation of cell growth and proliferation. In vascular smooth muscle,

PKC is present in relatively high concentrations. Smooth muscle cells freshly isolated

from renal artery express PKCa, 8, and

whereas cultured smooth muscle cells from

renal artery, after a certain number of passaging of the cultures, express PKC e in addition
to PKCa, 8, and £ (Assender et al., 1994). Rat smooth muscle cells from aorta express

37

1

PKC a, P, 8, e, and £ (Haller et al., 1995a), whereas smooth muscle cells from rat

coronary vessels express PKCa, 8,

and e (Leszczynski et al., 1996). In A7r5, a clonal

cell line of embryonic rat vascular smooth muscle, PKC a, p, 8, e, and £ were detected by
Western blot analysis of cell protein (Wang et al., 1997b), and PKC y and r| were added

to the list by Northern blot analysis of mRNA (Fukumoto, et al., 1997).

A wide variety of growth factors and hormones are thought to regulate vascular
smooth muscle cell growth and differentiation through PKC signaling pathways

(Chardonnens et al., 1990; Griendling et al., 1989) and evidence now exists suggesting

that PKC may have both proliferative and anti-proliferative effects in smooth muscle cells.

For example, Inui et al. (1994) showed that the mitogenic effect of PDGF was partially
mediated by PKC and Hirst et al. (1995) found that fetal bovine serum-induced
proliferation was blocked by PKC inhibitors. In contrast, Sasaguri et al. (1993) found that

acute phorbol ester treatment increasing PKC activity inhibited serum-stimulated DNA
synthesis and cell population doubling; whereas, chronic phorbol treatment

downregulated PKC and shortened the smooth muscle cell doubling time. In a similar

vein, Huang and Ives (1987) suggested that growth factor-stimulated DNA synthesis was
increased in PKC-depleted cells. Due to the expression of multiple PKC isoforms in

smooth muscle cells and evidence that different isozymes have a distinct role in cell

proliferation in other cell types, these paradoxical effects described above could be due
to the individual localization, activation, and function of PKC isozymes. However, little

information is available concerning the specific function of individual PKC isoforms and
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how they control smooth muscle cell proliferation. Overexpress of PKCa and PKC8 in
A7r5 smooth muscle cells indicated that both of them inhibit cell proliferation (Wang et
al., 1997b; Fukumoto et al., 1997). The effect of other PKC isozymes on smooth muscle
cell proliferation has yet to be determined.

PKC modulates gene expression through nuclear factors in smooth muscle cells.
Activation of cytosolic PKC leads to phosphorylation of lamin B in cultured smooth
muscle cells (Tsuda and Alexander, 1990), suggesting that cell surface activation of PKC

leads to nuclear events. Further studies have indicated a-adrenergic stimulation causes

PKC£ to translocate to the intranuclear compartment in smooth muscle cells (Khalil et al.,
1992) which may imply a role in this PKC isozyme regulatory gene expression. Addition
of angiotensin II to cultured rat aortic smooth muscle cells promoted the transcription of

the c-fos proto-oncogene; whereas, the downregulation of PKC totally inhibited the
induction of c-fos mRNA by phorbol ester and significantly reduced the increment in
mRNA levels produced by angiotensin II (Taubman, et al., 1989). Finally, PKC a

overexpression changed nuclear AP-1 binding to DNA; whereas, PKC8 overexpression
decreased the expression of cyclin DI and E (Wang et al., 1997b; Fukumoto et al., 1997).

These results clearly indicate the need for further studies of the PKC-activated nuclear
signal cascade in smooth muscle cells.

There is ample evidence to suggest that PKC plays a direct role in the regulation
of the contractile response of vascular smooth muscle (Rasmussen et al., 1984). PKC is

tonically activated in response to a variety of contractile stimuli (Haller et al., 1990; Singer
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et al., 1992), whereas PKC inhibition attenuates or blocks the response to different

agonists (Merkel et al., 1991; Shimamoto et al., 1993; Wright and Hum, 1994). Short
term exposure of vessels to phorbol esters results in a slowly developed but robust
contraction. In contrast, the long term exposure of smooth muscle to phorbol esters results
in the downregulation of the PKC protein (Wright et al., 1996) and a corresponding

attenuation in the contractile response to different agonists (Singer et al., 1992; Rapoport

et al., 1995). Various agonists induce PKC translocation in bovine carotid artery (Haller
et al., 1990) with the simultaneous development of contraction. PKC can serve as a

positive modulator of the extracellular Ca++-dependent component of the norepinephrineinduced contraction, and as a negative modulator of the component of the norepinephrineinduced contraction dependent on intracellular Ca++ release (Rapoport et al., 1995).
The exact mechanism of how PKC is involved in smooth muscle contraction is
still largely unknown. In one study, phorbol ester was shown to increase the sarcoplasma

free Ca*+ concentration with activation of Ca++/calmodulin-dependent myosin light chain
kinase, phosphorylation of the light chains of myosin and the development of force

(Walsh, 1991). On the other hand, others have reported that phorbol ester-induced
contractions occurred without a change in Ca++ or myosin phosphorylation (Singer, 1990).

PKC activation triggers the mitogen-activated protein (MAP) kinase cascade, leading to
phosphorylation of caldesmon and disinhibition of cross bridge cycling (Adam and

Hathaway, 1993) which could influence contraction. Alternatively, PKC activation could

influence contractile function through the remodeling of the tension bearing elements of
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the cytoskeleton (Battistella-Patterson et al., 1997).

PKC also plays an important role in mediating the effects of retinoids on cell
differentiation. For example, retinoic acid treatment causes differentiation of B16
melanoma cells (Niles and Loewy, 1991) and blocks B16 cells in the Gj phase of the cell

cycle (Niles, 1987). In these RA-treated B16 cells, an early induction of PKCa was
observed (Rosenbaum and Niles, 1992), which apparently plays a key role in the

differentiation pathway (Gruber et al., 1992). Expression of dominant-negative RARs
inhibited the induction of PKCa by retinoic acid (Desai et al., 1996). These data are

directly strengthened by the finding of a retinoic acid response element in the 5'-flanking
region of PKCa (personal communication with Dr. Desai). Co-transfection of RARs with
the promotor reporter gene of PKCa increases the luciferase activity several fold,
confirming the regulatoiy role of retinoid in the expression of PKCa. There is also
evidence to suggest the retinoic acid modulation of phenotype in vascular smooth muscle

involves an increase in the expression of PKC (Haller et al., 1995; Wright et al., 1996).

Haller and coworkers (1995) showed an increase in PKCa expression concomitant with
RA-induced differentiation of subcultured smooth muscle cells; whereas, Wright et al.
(1996) found retinoic acid increased the PKCa level in cultured aortic ring concomitant

with the preservation of contractile competence. Studies of the PKC-mediated effects of

retinoids in vascular smooth muscle cells will almost certainly further our understanding
of the mechanisms governing differentiation and contractile function.
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6. Summary

The structural and functional changes in the arterial wall of humans (Cichocki et

al., 1985) and animals (Mangiarua et al., 1981) that accompany the development of
hypertension and atherosclerosis are thought to play important roles in these diseases
(Folkow, 1982). Hence, great interest exists in the mechanisms that govern vascular

smooth muscle cell contraction and proliferation. It is well known that smooth muscle
changes its phenotype in culture from the "contractile” to the "synthetic” mode. The
alterations involved are truly significant and include the filling of the cytoplasm with

rough endoplasmic reticulum, the absence or sparse distribution of myofilaments and a

marked increase in the synthesis of DNA, RNA and protein.
The in vivo factors considered likely to contribute importantly to the contractile

competence and differentiation state of vascular smooth muscle include humoral factors,

mechanical stimulation (stretch) and cell-cell/extracellular matrix interactions. Among
these, the endothelium is a key regulator of the function and structure of the underlying

smooth muscle cell layers (Luscher and Tanner, 1993). As the interface between the
blood stream and the vessel wall, the endothelium appears to play both a sensor and

transducer role, signaling the underlying smooth muscle cell by releasing a myriad of

biologically active compounds. The endothelium has been shown to release factors which
enhance smooth muscle cell proliferation as well as factors which inhibit smooth muscle
cell growth, and it is likely that the balance of secretion of these endothelial derived

growth promoting and inhibiting factors represents an important parameter in determining
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the ultimate phenotypic status of the underlying smooth muscle cells. The predominant
effect of the endothelial cell layer on smooth muscle cell growth in vivo is inhibition.

Dysfunction of endothelial cells has been postulated to play a role in pathologies of the
major cardiovascular diseases, such as hypertension and atherosclerosis.

The retinoids represent a family of natural compounds including the alcohol

(retinol), the aldehyde (retinal), and the acid (retinoic acid) forms. They have been shown
to cause a wide variety of developmental changes in normal and malignant cell types

(Sherman, 1986; Sporn and Roberts, 1983). The majority of effects exerted by these
compounds are thought to be mediated by their ability to act as ligands for a family of
nuclear receptors which bind specific regions of DNA and affect the expression of target

genes. The retinoids are thought to be important for the development of the cardiovascular

system and the modulation of smooth muscle cell phenotype. Vitamin A plays an
essential role in the regulation of early smooth muscle development and differentiation.
The recent demonstration that all-trans RA was able to preserve contractile function in
cultured rat aorta (Wright et al., 1996), coupled with reports of the presence of functional
retinoic acid receptors in smooth muscle cells (Miano et al., 1996), strongly suggests a

role for the retinoids in maintaining smooth muscle cell differentiation in vivo.
In addition to their direct effect on smooth muscle cells, retinoids also regulate

vessel function and structure through endothelium-smooth muscle interaction. The
circulating level of retinol, the parent molecule of the retinoids, is rigorously maintained
at a concentration of approximately lO^M, and endothelial cells are chronically exposed
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to this relatively high level of the compound. Evidence available indicates that retinol
modulates the morphology and growth of endothelial cells, influencing their secretion of

proteins such as matrix-degrading protease and TGF-p. Existing data show that the

endothelial changes caused by retinoid favor the preservation of the contractile phenotype
of smooth muscle.
The retinoids exert their effects through the regulation ofgene expression. Protein

Kinase C pathway may be involved in this process. PKC is known to be a key enzyme in
signal transduction pathways that regulate cellular functions, including cell proliferation
and differentiation (Clemens et al., 1992). It comprises a multigene family that encodes
at least twelve different isoforms (Nishizuka, 1995), the expression of which varies

between tissues and cell types with individual isoforms performing different roles in

regulating cell function. Also, a wide variety of growth factors and hormones are thought
to regulate vascular smooth muscle cell growth and differentiation through PKC signaling
pathways. Due to the expression of multiple PKC isoforms in smooth muscle cells, the

effects of retinoids and growth factors must take into account levels of different isozymes,

their state of activation and their subcellular localization.
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Materials and Methods

Research Goals

The research goals of this project were to:
1.

Determine whether selected retinoids stimulate smooth muscle cell differentiation

in terms of smooth muscle contractility and proliferation.
2.

Determine whether retinoids regulate smooth muscle function through a protein

kinase C pathway.
3.

Determine whether PKCa has a possible role in regulating smooth muscle cell

differentiation.
An organ culture system was developed to evaluate rat aortic contractility after

several days in vitro. These studies showed that rat plasma effectively preserved the
contractility of smooth muscle, indicating the involvement of humoral factors. Because
of their potent differentiating effects and abundance in plasma, retinoids were added to

the organ culture system. It was found that retinoic acid exerted significant effects in the
preservation of contractile competence. A group of experiments were then conducted to

determine whether retinoic acid can affect other aspects of smooth muscle differentiation
such as proliferation and differentiation-specific protein expression. Retinol is the parent
molecule of retinoic acid and it exists in a high concentration in plasma. Using the newly

developed organ culture system, it was shown that retinol can significantly preserve
smooth muscle contraction for at least 7 days in culture. Electron microscopy was then
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utilized to further characterize the structural changes in the cultured tissue with or without

retinol treatment. Additional studies indicated the involvement of the endothelium in
retinol’s effect on the preservation of contraction. Consequently, a co-culture of smooth
muscle cells and endothelial cells was developed to study these interactions. Co-culture
data showed retinol-mediated release of growth inhibitory factors from the endothelial
cells to smooth muscle cells. Thus, further experiments were conducted using HPLC to

study retinol metabolism in endothelial cells and the release of metabolites into the culture
medium.

Because a major mechanism of retinoic acid action in influencing cell
differentiation is through the regulation of protein kinase C, experiments were conducted
to determine its effect on PKC in smooth muscle. The protein levels of several isoforms

expressed in smooth muscle were found to be changed by retinoic acid treatment. Finally,
the stable expression of PKCa in smooth muscle cells was used to evaluate specific

isoform function.

Animals
Male Sprague-Dawley rats, approximately 12 weeks of age, were purchased from
Hilltop Laboratories, Scottsdale, PA. The animals were housed in plastic tubs on chipped

wood. Animal rooms were maintained at 23±2°C at a 12-h photoperiod. Animals had free
access to tap water and Purina rat chow.
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Tissue Preparation and Organ Culture

Animals were anesthetized (ketamine:xylazine) by a modification of the method
of Furchgott and Bhadrakom (1953). The chest was opened by midline incision and the
thoracic aorta was removed and placed into warmed (37°C) Krebs solution (NaCl,

118mM; KC1, 4.7mM; CaCl2, 1.2mM; NaHCO3, 24mM; MgCl^ 1.1 mM; KH2PO4,

I.2mM; glucose, 5.6mM; pH, 7.4) aerated with 5% CO2 in O2. The vessel segments were
carefully rinsed of blood, cleaned of adherent tissue and cut into rings approximately
0.3cm in length.
Rings designated for organ culture were placed into gas-sterilized plastic bottles

containing 10ml of culture media. The “basic” media consisted of Lebovitz's L-15 media
containing lOOpg/ml of streptomycin, lOOU/ml of penicillin, and 0.25pg/ml of
amphotericin B. Culture bottles were modified to accept Millipore MILLEX-GV filters
at entry ports allowing oxygenation (100% O2, 2.5cc/min). Plasma was obtained by

cardiac puncture into heparinized syringes followed by centrifugation. Plasma from a

number of animals was pooled and used after freezing (-22°C) for intervals up to 6
months. Unless stated otherwise, the “plasma-supplemented” media refers to a 1:1 (v:v)

mixture of the basic media and plasma.

Cultured arteries were kept in a

temperature/humidity controlled incubator at 37°C and the media was changed on
alternate days. All-trans-retinol, all-trans retinoic acid and phorbol ester supplements

were delivered in dimethyl sulfoxide; control culture tissues received the DMSO vehicle.
All procedures using retinol, retinoic acid and phorbol esters were done under subdued
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light to minimize photo-oxidation. For experiments employing long-term retinol

treatment, half of the samples were used for contractility studies and the remainder were
processed for microscopic examination after a 7 day incubation.

Contractility Measurements

Each ring was suspended between a metal tissue holder and a L-hook and placed
in a 25 ml organ bath containing aerated (5%CO2 in O2) Krebs solution maintained at
37.4°C. The metal hook was connected to a Grass FT03D force transducer for the
measurement of isometric force. All rings were equilibrated for at least 1 hour under 2g
of passive tension prior to experimentation. A Grass polygraph was used to record

tension. In those experiments evaluating the role of the endothelium, vessels were
denuded of endothelium by gentle intimal rubbing with two metal needles (Wright and

Hum, 1994). The functional removal of endothelium was verified by the absence of
relaxation of rings contracted with 10'8M norepinephrine by acetylcholine (10‘5M).

A standard protocol was utilized for the assessment of contractile function. Tissues

were maximally contracted with potassium depolarization (80mM KC1), relaxed by
rinsing with fresh buffer, and contracted again with either potassium (80mM KC1) or
phorbol 12,13-dibutyrate (IO-6 M). Only one experimental procedure was performed with

each ring. Freshly isolated rings served as controls for cultured rings. In experiments

employing long-term retinol treatment, several rings from each treatment group were
concurrently fixed and processed for examination with the light and electron microscope.
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Light and Electron Microscopy
At the end of the culture period, aortic segments were rinsed three times with

Hank’s buffered salt solution (HBSS) at 37°C. The segments were fixed for 2 hours at 4°C
in 2% glutaraldehyde, buffered to pH 7.4 with 0.15 M sodium cacodylate, then postfixed
for 2 hours with 1% OsO4 (in 0.15 M sodium cacodylate, pH 7.4). Samples were

dehydrated using a series of ethanol solutions (30%, 50%, 70%, 90% and 95%) for 30
minutes each, followed by three periods of 30 minutes in absolute ethanol. The samples

were then switched to 50% Epon in ethanol for 2 hours and then to 100% Epon overnight.
Slow polymerization of resin was accomplished by a 24 hour incubation at 47°C followed
by 48 hours at 60°C.

Semi-thin (2pm) transverse sections were stained with toluidine blue and

observed under a light microscope. For transmission electron microscopy examination,
ultra-thin (80-1 OOnm) transverse sections of the thoracic aorta including the tunica intima
were collected on collodion gold-coated copper grids. Post section staining with 0.5%

uranyl acetate (25 minutes) was followed by water rinse. The sections were then stained
with 0.05% lead citrate solution (15 minutes), rinsed with 0.02NNaOH, and rinsed with
distilled water. Sections were viewed and photographed using a HITACHI H-7000/H7100 transmission electron microscope at an accelerating voltage of 75KV and 100KV.
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Smooth Muscle Cell Culture and Proliferation Assays

A7r5 smooth muscle cells derived from embryonic rat aorta (Kimes and Brandt,

1976) were obtained from the American Type Cell Collection (ATCC). This cell line has
been proven to be a useful model system for studying the effects of growth factors on
DNA synthesis, cell proliferation, and ionic flux (Owen, 1985; Sperti and Colucci, 1991).
A7r5 cells were routinely grown in Dulbecco’s Modified Medium (DMEM, Gibco)
supplemented with 10% Fetal Calf Serum (FCS) (Sigma Co.), 50 units/ml penicillin and

50pg/ml streptomycin and kept in a humidified atmosphere of 5% CO2 at 37°C. Medium
was changed every two days and cells were passaged once a week by using 0.05% trypsin-

EDTA in HBSS.

For proliferation assays, cells were seeded at a density of 5,000 cells/cm2 in 6 well
cell culture plates (Coming, New York) in 2.5 ml of complete DMEM +10% FCS and

allowed to attach overnight. Various concentrations of retinol or retinoic acid were

added to the media. At indicated intervals, cells were harvested by trypsin-EDTA and
counted in a cell counter (Coulter counter). The medium was changed every two days. All

procedures where retinol and retinoic acid were present were done under subdued light
to prevent photo-oxidation.

During proliferation assays, cell viability assays were also performed as follows:

Briefly, trypsinized A7r5 cells were mixed with trypan blue solution (0.2% w/w trypan
blue in PBS (pH 7.4)), and an aliquot placed in a hemocytometer. The blue stained cells
and the trypan blue excluding cells were counted separately so that a percentage of the
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viable cells was obtained. Treatments resulting in greater than 10% of cells taking up the
stain were considered toxic.

Bovine Aortic Endothelial Cell Isolation and Culture

Bovine aorta were freshly obtained from a local slaughter house (Logan Co.,
Huntington, West Virginia) and transported within one hour to the cell culture laboratory
in ice-cold sterile HBSS. After several washes with HBSS at room temperature, the aortae

were cut open with a scalpel blade and the bovine aortic endothelial cells (BAEC) were
removed using 1% collagenase (171U/mg) for 15 minutes. Cells were then placed into

DMEM, centrifuged and washed 3 times to remove collagenase. BAECs were cultured
in DMEM supplemented with 10% FCS, 100IU penicillin and lOOpg/ml streptomycin.

BAEC were identified by their typical cobblestone pattern, fluorescent staining for Factor

VIII antigen with monoclonal antibody (Sigma), and by the negative binding of smooth
muscle a-actin specific antibody (Sigma). Three different isolates of BAEC at passages
between the 4 and 10 were used for experiments. Medium was changed every two days
and cells were passed after confluence by using 0.05% trypsin-EDTA in HBSS. BAEC
were also stored in freezing solution (20% FCS and 10% dimethyl sulfoxide (DMSO) in

DMEM) under liquid nitrogen as stock at passage 4. Cells were placed in a l°C/min
Fischer cell freezing container at -70°C for 16 hours, whereupon they were transferred to
a liquid nitrogen holding tank.
To obtain conditioned medium, BAEC were grown to confluence in 75cm2 culture
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flasks. Cells were washed three times with HBSS and fresh DMEM with 10% FCS was
added in the presence or absence of 10'6M retinol. After 48 hours, the medium was

collected, centrifuged to remove suspended cells and stored at -20°C. Conditioned
medium was mixed at a 1:1 ratio with fresh DMEM media with 10% FCS and provided

as a growth medium for sparsely seeded A7r5 cells. This media were changed every two

days and A7r5 cells were counted at the 7th day. For co-culture experiments, BAEC and

retinol pre-treated BAEC were grown to postconfluence in 6 well plate inserts. The
inserts were then placed into 6 well plates containing sparsely seeded A7r5 cells (5,000
cells/cm2). The two cell types were separated by a porous membrane which allowed only

humoral communication. Medium was changed every 2 days and the A7r5 cells were
counted at the 7th day. Phase contrast photomicrographs of control and retinol-treated

BAEC were taken with a Nikon inverted microscope using Kodak p3200 black and white
film.

Western Blot Analysis
To collect protein samples from the rat aortae, cultured and freshly excised aortae

were put into ice cold phosphate buffered saline solution (PBS). The endothelial and
adventitial tissue were then removed. Strips of medial smooth muscle were immediately
homogenized in homogenization buffer (pH 7.5, 20mM Tris-HCL, lOmM EGTA, 2mM
EDTA, 2mM PMSF) at 4°C. Following low speed centrifugation (2,000g) to remove

debris and nuclei, the supernatant was sonicated by two 10s burst with a Tekmar sonic
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disrupter at power setting 60 and saved for protein concentration determination.
To collect protein samples from cell culture, cells were grown to confluence and

washed twice with ice-cold PBS. Then cells were scraped from the culture vessels and
collected. Harvested cells were suspended on ice in 250 pl of lysis buffer (lOmmol/L Tris,

pH 7.4; Immol/L EDTA; 1% glycerol; Ipg/ml leupeptin; Ipg/ml pepstatin; 50pg/ml
aprotinin; 0.5 mmol/L phenylmethysulfonyl fluoride), and disrupted by two 10-s bursts
from a Tekmar sonic disrupter at power setting 60.

Protein concentrations were determined by the BCA®(Pierce) protein assay.
Samples of equal protein concentrations were denatured in sample buffer (50mM Tris,
10% glycerol, 20mM DTT) at 100°C for 10 minutes before being subjected to 10%

Sodium Dodecyl Sulfate Polyacrylamide Gel electrophoresis (SDS-PAGE).

SDS-PAGE was performed using standard techniques (Lammeli, 1970). The
polymerization reaction was initiated in degassed acrylamide separation gel solution (10%

acrylamide, 0.09% N, N-methylene-bis-acrylamide (BIS), 0.1% SDS, 373mM Tris-HCl
pH 8.7) and was poured into a prepared electrophoresis plate apparatus. The
polymerization reaction was allowed to go to completion and a stacking gel (4.8%

acrylamide, 0.14% bis acrylamide, 0.1% SDS, 125mM Tris-HCl pH 6.9) was placed on
top of the separating gel. Polymerization of both the separating and stacking gel solutions
was initiated with the simultaneous addition of 0.05% N, N, N’, N’-tetramethylethyene

diamine (TEMED) and 0.05% ammonium persulfate. Protein samples were loaded in the
gel and the electrophoresis was carried out at 50 volts for about 16 hours.
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Proteins were electrically transferred to Trans-Blot® Transfer Medium
nitrocellulose membrane (Bio-Rad) by using a semi-dry Electrophoretic Transfer

Apparatus (Fischer). Briefly, blotting papers and Millipore (nitrocellulose and cellulose
acetate) filter paper were equilibrated in Schafer-Neilson transfer buffer (48mM Tris,

39mM glycine and 20% methanol) for at least 15 minutes. A sandwich of extra thick

blotting paper, filter paper, gel, and blotting paper was assembled from bottom to top of

the platinum electrode surface of the transfer apparatus. The transfer was run at 20 volts
for 15-25 minutes depending on the size of the gel. The blot was air dried and placed

between blotting paper for storage.
For immunoanalysis, the membrane was incubated for an hour at room

temperature in blocking solution (5% nonfat dry milk in Phosphate buffered saline, pH7.5,

containing 0.1% Tween-20) before primary antibodies were added. A 1:1000 dilution
were used for most primary antibodies except anti-PKCa antibody (lOpg/ml was used).
The incubation time for primary antibodies with the membrane varied from 1 hour to

overnight depending on the tested avidity of antigen-antibody binding. Blots were then
subsequently washed 3 times for 15 minutes each, whereupon the second antibody

solution containing the appropriate secondary antibody was added and allowed to incubate

for 1 hour at room temperature. The blot was then washed 4 times (15 minutes each) in
PBS-T (phosphate buffered saline with 0.5% tween 20) with vigorous shaking.

After the final wash the blot was drained of buffer and the excess was blotted dry
with tissue paper. ECL ® detection solution (Amersham) was added to the blot and
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incubated for 1 minute at room temperature. The blot was gently shaken to remove excess
detection reagent and wrapped in Saran Wrap with the air pockets gently removed. Under

safe light illumination, a Fuji x-ray autoradiography film was exposed to the protein side
of the blot for 15-90 seconds and developed using a Fuji RG11 x-ray film developer.

Immunoblots were quantified by 2D-densitometric scanning (ImageQuant, Molecular
Dynamics, Inc.) and the results were expressed in arbitrary units.
Monoclonal antibodies to the catalytic domain of Protein Kinase Ca were from

Upstate Biotechnology Inc. Monoclonal antibodies to Protein Kinase C P, y, 8, e,

rj, 0,

i, X, and p were purchased from Transduction Laboratories, KY. Monoclonal antibodies
to smooth muscle specific a-actin, vinculin, and desmin were purchased from Sigma

Chemical Co., MO. Monoclonal antibodies to p-actin and monoclonal antibodies reacting

with all isoforms of actin (total actin) were also purchased form Sigma Chemical Co.,
MO. Rabbit anti-mouse IgG horseradish peroxidase-conjugated secondary antibody was

from Amersham (Chicago).

Reversed-phase HPLC Chromatography of Retinol Metabolism in BAEC and A7r5
Cells

The content of retinol and its metabolites in endothelial cells and smooth muscle
cells was analyzed by reversed phase HPLC. BAEC and its comparison group, A7r5 cells,

were cultured in 10cm cell culture dishes until confluence and then treated with retinol
for 2 days. Media were collected as conditioned medium and lyophilized. Cells were
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washed (3X) with HBSS and homogenized. Homogenate or lyophilized conditioned

medium were extracted with 20 volumes of chloroform:methanol (2:1 v/v) and the total
lipid extract was fractioned on solid phase columns (Supelco Inc., PA) to separate the

retinoids from other neutral lipids. Briefly, the Solid Phase extraction tubes were
conditioned with 2ml acetonitrile, followed by 2ml of hexane. Total lipid extracts were
passed slowly through the tubes and neutral lipids were eluted with 5ml

chloroform/isopropanol (2:1). The remaining fractions were eluted with 5ml 2% acetic

acid in diethyl ether containing 0.01% butylated hydroxytoulene and collected. Samples

covered by a continuous layer of N2 gas to prevent oxidation were then evaporated to
dryness and re-dissolved in hexane/acetonitrile/acetic acid (99.5:4:1).

HPLC analyses were performed on a Waters Nova-Pak C18 stainless steel column
(60A, 4pm, 3.9X300mm) and, for convenience, preparative separations were carried out
on a Radial-Pak cartridge (Waters, Cl 8, 8x100 mm). All assays were done with a Waters

HPLC system consisting of a model 600E controlling unit, a model 610 solvent delivery

system, a model 700 satellite WISP, a model 490E UV/vis detector, and the Millennium
2010 software package. Degassed HPLC elution solvent consisted of acetonitrile/

methanol/ isopropanol/ H2O/ acetic acid (30/26/15/22.5/1) and flow rate was Iml/min.
The detection wavelength was 345nm. Authentic standards such as retinol acetate, all-

trans retinol, all-trans retinal, 13-cis retinal, all-trans retinoic acid, 9-cis retinoic acid, and

13-cis retinoic acid were purchased from Sigma Chemical Co., MO.
In order to determine retinol metabolites in both conditioned medium and cell
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extracts, trace amounts of all-trans retinol (11,12-3H(N)) (NEN Research products, MA)

were mixed with nonradioactive retinol and added to cell culture. Conditioned medium
and cell extracts were collected as described above. Samples were extracted with Solid
Phase tubes and fractionated by HPLC. After breakthrough, HPLC elute was collected
every 30 second in 10 ml of Scintiverse E (Fisher Scientific, PA) and counted with a

Beckman LS-5801 liquid scintillation counter. Recoveries of retinol ranged from 50-60%

as measured by radioactivity.

Stable Transfection of PKCa in A7r5 Smooth Muscle Cells
Low density A7r5 cells were co-transfected with a PKCa cDNA expression vector
(YK504) (Ohno et al., 1988) driven by a SRa promotor (Takebe et al., 1988) and the

pSV40-neo plasmid encoding the gene for neomycin resistance, at a 1:10 ratio (pSV40neo:YK504). Transfection was accomplished by the calcium phosphate precipitation

procedure (Sambrook et al., 1989). Cells transfected with only pSV40-neo (neo) served
as negative controls. Cells were cultured in serum free medium for 24 hours and then

switched to DMEM supplemented with 10% FCS. Two days later cells were refed with

DMEM plus 10% fetal bovine serum containing 400pg/ml of neomycin derivative G418
(Gibco) and neomycin-resistant clones were selected. Individual clones were isolated

and grown in DMEM with 10% FBS containing 1 OOpg/ml of G418 as individual lines for
a month and thereafter grown in DMEM with 10% FBS. Cells at passages 4 to 8 post

transfection were frozen in liquid nitrogen as stocks.
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RNA extraction and Northern Analysis

Neomycin-resistant clones were grown in 100mm dishes and cells were harvested
at confluence by washing with cold (4°C) PBS, scraping into cold PBS and centrifuging
at 1,000 x g for 2 minutes. The cell pellet was suspended in 500p.l GIT (4moI/L

guanidinium isothiocyanate; 0.1 mol/LTris-HCl, pH7.5; 1% P-mercaptoethanol), passed
through a 18g needle fitted to 1ml syringe for 10-12 passages, and the resulting

homogenate was stored at -70°C until analysis. Total RNA was isolated by the guanidium
isothiocyanate-phenol-chloroform single step method as described by Chomczynski and
Sacchi (1987). The final RNA pellet was dissolved in diethylpyrocarbonate- (Sigma)
treated water and the concentration of RNA was determined by absorbance at 260nm.

Total

RNA

(25pg/lane)

was

electrophoretically

separated

on

1%

formaldehyde/agarose gels containing 20 ng/ml of ethidium bromide. The fractionated
RNA was transferred to Amersham Hybond-N nylon membrane by the downward transfer
method (Chomczynski, 1992) for 1.5 hours. The membrane was then neutralized in 0.2

mol/L phosphate buffer (pH 6.8) for 10 min and the transferred RNA was cross-linked
to the nylon membrane by aUV cross-linker (1200Joul) (Fisher Scientific). cDNA probes

were labeled by a random priming labeling kit (Promega) using [32P]dCTP (3,000

Ci/mmol) (Amersham) to a specific activity of approximately 1x109 cpm/pg. The
membrane was pre-hybridized in a solution containing 6x sodium chloride/ sodium citrate

solution (SSC), 2% SDS, and 5x Denhardt’s solution at 65°C for 30 min. The radioactive

probe was then added at a concentration of approximately IxlO6 cpm/ml. After overnight
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hybridization at 65°C, the membrane was washed twice at room temperature in 0.2x SSC
containing 0.1% SDS for 15 min each, followed by two washes for 30 min at 65°C in
O.lxSSC containing 0.1% SDS. The blot was exposed to XAR Kodak autoradiograph

film (Kodak) at -70°C with intensifying screens, and the signal intensity was quantitated
with a Molecular Dynamics densitometer. RNA loading was normalized by probing the

same membrane with GADPH cDNA (ATCC). A cDNA probe recognizing both a-actin

and p-actin was kindly provided by Dr. Gary Owens (University of Virginia, Virginia).
Northern blots presented in this study were representative of three different experiments.

Isolation and Preparation of Nuclear Extracts
Cells from different clones were washed twice with ice cold PBS, then scraped

into PBS and collected by centrifugation. NP-40 lysis buffer (lOmmol/LTris-HCl, pH7.4,

3mmol/L CaCl2, 2mmol/L MgCl2 and 1% NP-40) was used to disrupt cells. Nuclei were
recovered by centrifugation (500xg) and washed twice with ice cold NP-40 lysis buffer.

The nuclear pellet was then resuspended in extraction buffer (0.05mol/L Tris-HCl, pH
7.4, 10% (v/v) glycerol, 0.01 mol/L monothioglycerol, Immol/L EDTA, 0.001 mol/L

PMSF, 0.6 mol/L KC1, and 2mg/ml each of aprotinin, leupeptin, and pepstatin) and
sonicated twice with bursts of 10s each using a Tekmar sonic disrupter at power setting

60. The crude extract was incubated for two hours at 4°C and centrifuged at 100,000g for
1 hour to obtain a soluble nuclear extract.
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Electrophoretic Mobility Shift Assay
Two 23 base DNA oligonucleotides (Gruber et al., 1995) containing an AP-1

consensus sequence 5'-CGCGTCGACGCATGAGTCAGACA-3' and two 23 base DNA
oligonucleotides

containing

a

mutated

AP-1

consensus

sequence

CGCGTCGACGCAgGAGTCAGACA-3* were synthesized by the Marshall University

Protein/DNA Laboratory. These two sets of oligonucleotides were annealed to form a
double stranded oligonucleotide and labeled with [32P] dCTP (3000 Ci/mmol) by end
filling of the 5' protruding termini with the Klenow fragment of DNA polymerase I. The

labeled AP-1 oligonucleotides were purified using a Qiagen Tip-20, precipitated with 10
mg of glycogen carrier in ethanol:acetone (1:3) at -70°C and resuspended in ddH2O. Gel

shift reactions typically contained lOpg of nuclear extract, 10%(v/v) glycerol, 1 Ox reaction

buffer (0.2mol/L Hepes, pH 7.9, 0.6 mol/L KC1, 0.01 mol/L EDTA, O.lmol/L
monothioglycerol, and 0.01 mol/L PMSF), Ipgpoly (dldC), and 2x104 cpm of [32P] AP-1
oligonucleotides in a 20pl total volume. The reactions were incubated for 30 min at 22°C

and immediately resolved at 20mA in a 5% non-denaturing gel (60:1 acrylamide.bis) in

0.5X TBE (45mmol/L Tris borate, pH 8.0, 1 mmol/LEDTA). Dried gels were exposed to

film between intensifying screens at -70°C.

Statistical Analysis
Data are expressed as the mean ± S.E.. Values among groups were compared

statistically by analysis of variance followed by student-Newman-Keuls ’ test. P values
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<0.05 were accepted as denoting statistically significant difference. All statistical analysis
were performed using Sigma Stat Software (Jandel Scientific, Menlo Park, CA) for
Windows.
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Results

Effects of Retinoic Acid on Smooth Muscle Differentiation

1. Contractility

The effect of retinoic acid on the smooth muscle differentiation was first studied
in the vessel organ culture system utilizing contractile responsiveness as an index of cell

differentiation. The maximal response of rat aortic rings to potassium depolarization was
dramatically reduced (-60%) within 24 hours of being removed from the animal and

placed in the basic Lebovitz’s L-15 media (Fig. 1A). Aortic rings cultured in media

containing 50% rat plasma were significantly more responsive to potassium than those
cultured in the basic media, but were less responsive (-42%) than fresh tissue controls.

The addition of RA to the basic media did not significantly improve the tissue response
to potassium. By comparison, the addition of RA to the plasma-supplemented media
resulted in a marked increase in response to near (-14%) the values obtained for fresh

tissue controls. Similarly, the 24 hour culture of aortic rings in the basic media caused a

marked reduction (-66%) in the response to phorbol 12,13-dibutyrate compared to fresh
tissue controls (Fig IB). In contrast to the reduced response to potassium, tissues cultured

in plasma-supplemented media showed no loss in responsiveness to the phorbol ester,
compared to fresh tissue controls. The addition of lO^M RA to the basic media

significantly increased the maximal response to the phorbol ester in aortic rings cultured
in either the basic media (+68%) or the plasma-supplemented media (+21%).
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Fig. 1 The effect of rat plasma and retinoic acid (+RA) supplementation of culture media

on the maximal contractile response to A) 80mM potassium and B) lO^M phorbol 12,13dibutyrate by rat aortic rings cultured for 24 hours. Data are compared to freshly excised
tissue controls (FTC) and to rings cultured in basic Lebovitz’s L-l 5 media (basic). An *,

f, or } indicates a significant difference from FTC, basic, or plasma vs plasma +RA,
respectively.
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In a second series of experiments, the effects of rat plasma and plasma + RA

supplements of the basic media on the maximal response to potassium and phorbol ester
were examined in aortic rings maintained in organ culture for up to 72 hours (Fig.2). The
results indicate that tissues cultured in plasma-supplemented media maintain a relatively

constant response to potassium depolarization at about 55% of fresh tissue values over the

three-day interval (Fig.2A). The addition of 10‘6M RA to the media fully restored the
contractile response to potassium at 24 hours and 48 hours, but the response was

significantly reduced (-33%) at 72 hours. The maximal response to phorbol 12,13dibutyrate at 24 hours was unchanged and significantly increased in aortic rings from

plasma and plasma+ RA - supplemented media, respectively (Fig.2B). However, the
response to phorbol ester in both of these treatment groups was reduced compared to fresh

tissue values (-36%) at 48 hours and 72 hours.

The data summarized in Figure 3 again demonstrate the partial effectiveness of
plasma supplementation of the media in preserving the maximal response to potassium

(Fig.3A); whereas, this treatment resulted in full maximal response to phorbol 12,13dibutyrate (Fig.3B) in aortic rings cultured for 24 hours. Additions of RA to the plasmasupplemented culture media resulted in a roughly concentration-dependent degree of

preservation ofthe response to potassium. Similar concentrations of RA had no significant
effect on the maximal response to the phorbol ester with the exception of lO^M RA,
which resulted in a supramaximal contraction.
Removal of the endothelium prior to 24 hour organ culture of the vessel segments
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Fig. 2 The effect of supplementation of Lebovitz's L-15 media with rat plasma (•) and
plasma 4- RA (O) on the maximal contractile response to A) potassium and B) phorbol

12,13-dibutyrate of rat aortic rings cultured for up to 72 hours.
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significant difference from freshly excised tissue controls (solid bars).
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Fig. 3 The effect of varying the media concentration of retinoic acid (RA) on the
contractile response to A) 80mM potassium and B) lO^M phorbol 12,13-dibutyrate of rat
aortic rings cultured for 24 hours in the plasma-supplemented media. An * or f indicates

a significant difference from freshly excised tissue controls (FTC) or tissues cultured in
plasma-supplemented media without RA addition, respectively.
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altered the effect of plasma and RA treatments on the maximal response to potassium
(Fig.4). The loss in response to potassium by rubbed rings cultured in the basic Lebovitz's
L-l 5 media (-38%) was less severe than that noted in comparably treated unrubbed tissues

(-60%) (Fig. 1 A). However, the supplementation of the media with 10^M RA, 50% rat

plasma, or these two in combination did not result in a significant increase in the response
of the rubbed aortic rings (Fig.4) as noted in unrubbed tissues.
The sensitivity of both unrubbed and rubbed tissues to potassium depolarization

was significantly reduced after 24 hours in organ culture using the basic Lebovitz’s L-l 5

medium (Table 3). The addition of RA, plasma, or the two in combination to the medium

increased the sensitivity to potassium in unrubbed tissues compared to those in the basic
media. These treatment also restored the EC50 values to fresh tissue control levels in

unrubbed tissues; whereas, no obvious effects were noted in rubbed rings.
The incubation of aortic rings with a high (lO^M) concentration of phorbol 12,13-

dibutyrate for 24 hours prior to contractility measurements significantly reduced the
maximal response to potassium (Fig.5A) but not to phorbol 12,13-dibutyrate (Fig.5B).

This effect of tissue incubation with phorbol ester was reversible as evidenced by the fact

that phorbol-treated tissues that were thoroughly rinsed and returned to organ culture for
an additional 24 hours in media containing lO^M RA showed an elevated response
compared to control tissue (Fig. 5).
Twenty-four hour incubation of aortic rings in the basic Lebovitz’s L-l5 media

caused a decreased expression of PKCa, while the addition of RA to the basic media
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Fig. 4 The effect of denuding aortic segments of endothelium by intimal rubbing on the
maximal response to 80 mM potassium of tissues maintained in organ culture for 24 hours.
Treatment groups include: the basic Lebovitz's L-15 media (-Basic), Basic plus lO^M

retinoic acid (+Basic), plasma-supplemented (-Plasma) and the plasma-containing media
plus lO^M retinoic acid (TPlasma). An * indicates a significant difference from freshly

excised tissue controls (FTC).
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Table 3. The EC50 values derived from concentration-response curves for potassium
(mM) of rubbed and unrubbed aortic rings.

FTC

Basic

+RA

Plasma

Plasma-FRA

Unrubbed

19.8±2.1

30.5±4.0*

23.3±2.1t

22.0±2.4t

20.5±l.lt

Rubbed

14.0±1.4

22.8±2.2*

19.4±1.1*

19.1 ± 1.1*

19.3±1.0*

Values are means + SE. Rings were freshly prepared (FTC) or cultured for 24

hours in basic Lebovitz's L-15 medium (Basic), in the basic medium supplemented with
10’6M retinoic acid, (+RA), medium containing 50% rat plasma (Plasma) or medium

containing both the plasma and retinoic acid additions (Plasma +RA). *, + significant
difference from FTC or Basic values respectively.
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Fig. 5 The effect of incubation with lO^M phorbol 12,13-dibutyrate (phorbol) on the

maximal response to A) 80 mM potassium and B) 1 O^M phorbol 12,13-dibutyrate of aortic

rings cultured for 24 hours in plasma-supplemented media. Subsequently, phorbol-treated
rings were thoroughly rinsed and cultured for an additional 24 hours in the presence of
retinoic acid (RA). Control tissues were cultured for 24 or 48 hours in the plasmasupplemented media without phorbol 12,13-dibutyrate or RA additions. An asterisk

indicates a significant difference from the appropriate control value.
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restored its expression (Fig. 6). The addition of plasma or plasma plus RA to the media
resulted in a marked increase in the level of PKCa. By comparison, the 24 hour incubation

of the tissue with lO^M phorbol 12, 13-dibutyrate antagonized the effect of plasma and
resulted in a marked depletion of PKCa protein levels.

2. Cell proliferation

The effect of retinoic acid on smooth muscle differentiation was also studied in a
cell culture system, using proliferation and expression of differentiation proteins as indices

of cell differentiation. The A7r5 cell line derived from embryonic rat thoracic aorta (Kimes

and Brandt, 1976) was used as a model. The addition of lO^M RA to the medium

decreased the growth of A7r5 cells with the maximum effect achieved between the 8th and
10th day of treatment (Fig. 7). This inhibitory effect on cell growth appeared to be dose

dependent (Fig. 8). At the 8th day of treatment, 10’8M RA significantly lowered the
number of cultured A7r5 cells, while lO^M RA exerted the best inhibition of cell

proliferation. 10'5M RA was found to be toxic to A7r5 smooth muscle cells as determined

by the trypan blue exclusion assay.

Five PKC isoforms were identified in A7r5 cells, including two conventional
isoforms (PKCa and PKCP), two novel isoforms (PKC8 and PKCe), and one atypical

isoform (PKCQ (Fig. 9). The addition of 1 pM RA resulted in a 25% increase of PKCa
expression, 3 fold increase of PKCe expression, a 35% increase of PKC8 expression, and
had no effects on the expression of PKCP and PKC£. Phorbol 12, 13 dibutyrate down-

regulated the expression of PKC a, P, e, and 8, but did not affect the level of PKC£. The
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Fig. 6 Western blot analysis of PKCa expression in 24 hour cultured aortae and the effect

of plasma and RA on their expression. A) PKCa content was assessed by immunoblotting
with monoclonal antibody. Rat brain was used as a positive control (lane 1). Samples

from aortae cultured in different media were loaded in lanes 2-6 (lane 2, Basic L-15 media;

lane 3, Basic+RA media; lane 4, 50% rat plasma supplemented media; lane 5, plasma+RA
supplemented media, lane 6, plasma+PDB supplemented media). Lane 7 was protein from

freshly excised aortae. B) Bar graph showing PKCa content of 24 hour cultured and fresh
aortic rings. Quantification of the PKCa specific bands was performed by densitometry
and expressed in arbitrary units.
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Fig. 8 The effect of varying concentration of retinoic acid on A7r5 smooth muscle cell
proliferation. Cells were seeded at 5,000 cells/cm2 and counted after 8 days of treatment.
An * indicates a significant difference from the control cells cultured in regular medium.

Each bar represents the average of 3 experiments.
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Fig. 9 Western blot analysis of PKC isozyme expression in A7r5 smooth muscle cells and

the effect of RA and PDB on their expression. Confluent A7r5 cells were treated with
vehicle, 1 pM RA or 1 pM PDB for 48 hours. Samples were collected and sujected to SDSpolyacrylamide gel electrophoresis and immunoanalysis. Lane 1, rat brain served as

positive control; Lane 2, vehicle treated control; Lane 3, cells treated with 1 pM RA; Lane
4, cells treated with IpM PDB.
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induction of PKC e and 5 expression in A7r5 cells by retinoic acid was time dependent.
A retinoic acid effect was evident at 12 hours after treatment (Fig. 10). Smooth muscle
specific desmin, vinculin, and a-actin levels were not significantly altered by 2 day RA

treatment. Down-regulation of PKC by long term phorbol ester treatment decreased the
expression of desmin (17%) and a-actin (57%) without changing the expression of vinculin

(Fig- ID-

Effects of Retinol on Smooth Muscle Differentiation and The Metabolism of Retinol
in Endothelial Cells

In light of the effects of RA, it was of interest to examine the effects of the parent

molecule, retinol, on smooth muscle differentiation. After 7 days in culture, plasma

supplementation was found to significantly improve the contraction of cultured rings to K+
depolarization (20%) (Fig. 12A) and to phorbol 12, 13-dibutyrate (PDB) (Fig. 12B) as

compared to rings cultured in the basic Leibovitz’s L-15 medium. The addition of lO^M

all-trans retinol to the culture medium supplemented with 50% plasma resulted in the
further increase of the maximal K4 contraction to nearly 40% of that in freshly isolated

aortic ring segments. By comparison, the PDB contraction was found to be less sensitive
to restoration by either plasma or plasma plus retinol treatment, showing maximal recovery
at only 17% of the value obtained in freshly isolated tissues.

Several aortic rings from each cultured group were processed for examination by

light and electron microscopy. Cultured tissue was not found to have obvious neointima
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Fig. 10 Effect of lO^M retinoic acid on the PKCe and PKC8 expression in A7r5 smooth

muscle cells. A7r5 cells were treated with or without IpM retinoic acid and collected at
indicated time intervals.

Western blot analysis were performed by using specific

monoclonal antibodies. Rat brain was used as a positive control.
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Fig. 11 Effect of RA and PDB on the expression of differentiation markers in A7r5 smooth

muscle cells. Confluent A7r5 cells were treated with vehicle, IpM RA or IpM PDB for
48 hours. Samples were collected and subjected to SDS-polyacrylamide gel electrophoresis

and immunoanalysis. Lane 1, vehicle treated control; Lane 2, cells treated with IpM RA;
Lane 3, cells treated with 1 pM PDB.
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Fig. 12 The effect of plasma (50%) and retinol (lO^M) supplementation of basic L-15

medium on the contractile response to 80mM potassium (A) and lO^M phorbol-12, 13dibutyrate by rat aortic rings cultured for 7 days. Each bar represents the average of 4
experiments. The * or + indicate a significant difference from the basic media and the

plasma supplemented media, respectively. Results were expressed as a percentage of the

maximum contraction of freshly isolated rat aortae.
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formation, cell death or necrotic lesions as compared to freshly isolated aortic rings (Fig.

13). Endothelial cells were intact in most tissues, while retinol segments had a thicker
intimal layer. Some loss of ultrastructural complexity of the cultured tissues was observed
under the electron microscope (Fig. 14). The most striking differences in morphological
appearance of the cultured tissues occurred within the endothelial cell layer, where

endothelial cells were found to have lost their highly convoluted surface. Aortic rings

cultured in plasma -supplemented medium had a similar magnitude of subendothelial space
as fresh controls and the addition of IO"6 M retinol increased this space.

Removal of the endothelium before culture of the vessel segments altered the effect

of retinol treatments on the maximal response to potassium (Table 4). Aortae cultured in
50% plasma-supplemented medium showed no significant differences between rubbed and

unrubbed tissue in response to PDB stimulation. However, the preservative effect of retinol
on the contractile response to potassium was lost when the endothelium was removed.

Removal of endothelium had no effects on the PDB-stimulated contraction.
Because the effects of retinol on the contractility of cultured aorta appeared to be
mediated by endothelial cells, we employed cultured bovine aortic endothelial cells
(BAEC) and the A7r5 smooth muscle cell line to determine the effect of retinol on smooth

muscle cell proliferation. Physiological concentrations of retinol had no direct effects on

the growth (Fig. 15) and morphology of A7r5 cells. In contrast, lO^M retinol was found
to change the morphology of bovine aortic endothelial cells (Fig. 16). In the presence of

retinol, BAEC were flat in appearance and formed a monolayer at confluence. Untreated
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Fig. 13 Light microscopic examination of sections from freshly excised rat aortic rings (a)

and those cultured for 7 days in medium supplemented with 50% adult rat plasma (b), and
plasma-supplemented medium containing 10^M all-trans retinol (c), or lO^M phorbol 12,

13 dibutyrate (d). Magnification X 100.

■
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Fig. 14 Electronmicrographs of sections from freshly excised rat aortic rings (a) and those

cultured for 7 days in medium supplemented with plasma (b) and plasma containing lO^M
all-trans retinol (c) or lO^M phorbol 12, 13 dibutryate (d). Magnification X 8,000.

Sections emphasize differences in endothelial cell (EC) morphology and development of
the subendothelial space (SES).
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Table 4. The effect of the removal of the endothelium (rubbed) on the contractile response
to 80mM potassium and lO^M phorbol 12,13 dibutyrate of rat aortic rings cultured in vitro
for 7 days. The medium of all cultures employed in these studies was supplemented (50%)

with adult rat plasma. Aortic rings were cultured in the absence (control group) or presence
(Retinol group) of IpM retinol. A total of 9 to 14 aortic segments were used in each
group. Data are expressed as percentage of maximum fresh tissue response.

Phorbol 12, 13 dibutyrate

Potassium
Control

Retinol

Control

Retinol

Rubbed

11.1 ± 1.3

14.3 ±2.9

15.1 ±2.0

18.0 ±3.4

Unrubbed

20.8 ± 4.5f

37.2±2.5*f

12.0 ±2.4

17.7 ±2.6

f P<0.05 vs rubbed tissue
* P<0.05 control vs retinol-treated
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Fig. 15 The effect on cell proliferation of three concentrations of all-trans retinol added

directly to the medium of cultured A7r5 smooth muscle cells. Each point represents the
average of 3 experiments.
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Fig. 16 Phase contrast photography of untreated control (a) and all-trans retinol-treated (b)

bovine aortic endothelial cells.
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control cells did not become quiescent upon reaching confluence but were found to
overgrow the monolayer.

The presence of postconfluent BAEC resulted in about a 15% inhibition of the

A7r5 growth (Fig. 17). Retinol treatment of the endothelial cells was found to significantly

increase the inhibition, effectively doubling the endothelial inhibitory effect on cell growth.
This conclusion was supported by the finding that medium conditioned by endothelial cells

exposed to retinol also had smooth muscle cell growth inhibitory properties (40%
inhibition), but that the conditioned medium collected from untreated, control BAEC had

no effects on A7r5 cell proliferation (Fig. 18). These data support a retinol-initiated
increase in the endothelial release of smooth muscle cell growth inhibitory factors and
demonstrate the relative stability of these factors, as they were found to retain potency

through at least one freeze-thaw cycle.

Retinol could exert its effects through two mechanisms: (i) increasing inhibitory
growth factor (such as TGF-0) release by the endothelium, or (ii)metabolism by the

endothelium into active compounds such as retinoic acid and local release. To test the
second hypothesis, retinol metabolism was examined in both smooth muscle cells and
endothelial cells by using reverse phase HPLC. Fig. 19 shows the typical chromatograph

of various retinoid standards eluted from the Cl 8 column. Cell extracts from BAEC and
A7r5 had similar HPLC profiles with the exception of one peak appearing in BAEC

extracts at a retention time of approximately 8 minutes (Fig. 20 and Fig. 21). Conditioned
medium collected from A7r5 and BAEC showed obvious differences in their HPLC
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Fig. 17 The effect on cell proliferation of the coculture of A7r5 smooth muscle cells with

untreated control and retinol-treated (lO^M) bovine aortic endothelial cells. The results
are compared to the proliferation rates of control or retinol-treated A7r5 cells in

monoculture. An * or + indicates a significant difference from either the monoculture
control or coculture control, respectively.
experiments.
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Fig. 18 The effect on A7r5 smooth muscle cell proliferation after addition (1:1) of
conditioned medium (CM) from either untreated control or all-trans retinol-treated (1 O^M)

bovine aortic endothelial cells. The results are compared to the proliferation rates of

control and retinol-treated A7r5 cells grown in regular medium. An asterisk indicates a
significant difference from the controls cultured in regular medium. Each bar represents

the average of 3 experiments.
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Fig. 19 Reversed-phase HPLC chromatogram of a mixture of various retinoid standards

on Nova-Pak Cl8 column. The mobile phase was described in Materials and Methods, flow
rate was Iml/minute, detection at 345nm. All standards were from Sigma Chemical Co..
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Fig. 20 Reverse-phase HPLC chromatogram of extracts of all-trans retinol-treated A7r5
cells. Confluent A7r5 cells were treated with 1 pM all-trans retinol for 2 days, pelleted and

extracted for lipid soluble compounds. Fractions were separated through Nova-Pak C18
column at a flow rate of Iml/minute and dectected at 345nm.
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Fig. 21 Reversed-phase HPLC chromatogram of extracts of all-trans retinol-treated bovine
endothelial cells (BAEC). Confluent BAECs were treated with IpM all-trans retinol for
2 days, pelleted and extracted for lipid soluble compounds. Fractions were separated

through Nova-Pak C18 column at a flow rate of Iml/minute and dectected at 345nm. “a”

indicate a unique peak compared to the HPLC profile of A7r5 cell extraction.
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profiles. Specifically, four peaks eluting at 8 to 12 minutes were observed in conditioned
medium collected form BAEC but not A7r5 cells (Fig. 22 and Fig. 23). To test whether
these peaks were metabolites of retinol, trace amounts of H3-all-trans retinol was added to

the cell cultures. Conditioned media were collected and fractions from the reverse phase
C-18 column were counted for radioactivity (Fig. 24). Each of the peaks showed

radioactivity levels above baseline and appeared to be more hydrophilic than retinol.

However, these four peaks failed to be identified as any specific derivatives due to the lack
of authentic standards. None of these HPLC fractions from BAEC conditioned medium

could be determined to have significant growth effects on A7r5 cells (Fig. 25). These data

indicate that endothelial cells actively metabolize retinol and release soluble retinoid
derivatives. However, the lack of growth inhibitory activity suggests that retinol
metabolites may not play an important direct role in inhibition of smooth muscle cell

growth by the endothelium.

The Role of PKCa Isozyme in A7r5 Smooth Muscle Cell Differentiation
Retinoic acid treatment increased PKCa expression in smooth muscle (Fig. 6 and

Fig. 9) concurrent with its preservation of contractile responsiveness. Stable expression of

PKCa in A7r5 smooth muscle cells was then employed to delineate its specific role in
smooth muscle cells.

A total of eight G418-resistant clones were recovered from PKCa cDNAtransfected cell cultures and confirmed to have increased PKCa protein levels. All of these
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Fig. 22 Reversed -phase HPLC chromatogram of conditioned medium from A7r5 smooth
muscle cells treated with retinol. Confluent A7r5 cells were treated with IpM all-trans

retinol for 2 days and the medium was collected as conditioned medium (CM). CM was
further lyophilized and extracted for lipid soluble compounds. Fractions were separated
through Nova-Pak C18 column at flow rate of Iml/minute and dectected at 345nm.
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Fig. 23 Reversed -phase HPLC chromatogram of conditioned medium from BAEC treated
with retinol. Confluent BAECs were treated with IpM all-trans retinol for 2 days and

medium was collected as conditioned medium (CM). CM was further lyophilized and

extracted for lipid soluble compounds. Fractions were separated through Nova-Pak C18

column at a flow rate of Iml/minute and detected at 345nm. “a, b, c, d” indicate peaks

present in HPLC profile of BAEC but not A7r5 cell conditioned medium.
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Fig. 24 Comparison of radioactivity of HPLC fractions of conditioned media from A7r5
cells and BAECs treated with H3-retinol. Trace amount of H3-all-trans retinol was mixed

with 1 pM retinol and added to confluent A7r5 and BAECs for 2 days. Conditioned media
were collected and fractionated through Nova-Pak C18 column at a flow rate of Iml/minute

and detected at 345nm. Fractions were counted for radioactivity, “a, b, c and d” indicate

peaks of radioactivity present in samples from BAEC but not A7r5 cells.
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Fig. 25 Effects of HPLC fractions of conditioned medium from retinol treated BAECs on

A7r5 smooth muscle cell proliferation. Conditioned medium from confluent BAECs

treated with IpM all-trans retinol for 2 days was separated through a Nova-Pak C18
column. Samples were collected through HPLC, concentrated and applied to A7r5 smooth
muscle cells at the 2nd day after seeding. A7r5 cells were seeded at 5,000 cell/cm2 and

treated with fractions from HPLC separation for 4 days before at which cells were

harvested and counted. Fl, samples collected between breakthrough and 10 minute of
retention time; F2, samples collected between 10 and 20 minute; F3, samples collected

between 20 and 30 minute; F4, samples collected after 30 minutes.
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clones had obviously slow growth rates and altered morphology as compared to the wild

type A7r5 cells. Two representative clones were selected for further study, clone M
(moderately overexpressing) and clone H (highly overexpressing). Utilizing both Western

(Fig. 26) and Northern blot analysis (Fig. 27), it was determined that clone M and clone

H contained approximately 4-fold and 10-fold increases in PKCa protein levels, and 4-fold

and 12-fold increases in PKCa mRNA levels, respectively, compared to wild type cells
and a clone of cells transfected with only the neomycin-resistant gene.
Growth rates were seen to inversely correlate with PKCa levels in thi
overexpression clones (Fig. 28). Cells from clone M and H had significantly lower growth

rates compared to wild type cells and the neomycin-resistant clone (Fig. 28A). At day 10,
M and H clones reached a cell density of only one half that of control cells and the cell

density was significantly lower in the H clone compared to the M clone. Compared to

control cells, PKCa overexpressing clones exhibited a flatter appearance, loss of the
spindle shape (Fig. 29), and numerous intracellular vesicles under phase contrast
microscopy.
To test whether changes in the differentiated phenotype accompanied the lower

growth rates in PKCa overexpressing clones, the protein levels of differentiation markers

(vinculin, desmin and smooth muscle-specific a-actin) were examined (Fig. 30). Western
blot analysis showed that the levels of the matrix adherent junction protein vinculin and
the intermediate filament protein desmin were not affected by PKCa overexpression. In

contrast, smooth muscle-specific a-actin level was downregulated in both of the PKCa
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Fig. 26 Western blot analysis of PKCa overexpressing clones. A: Equal amounts of

protein (lOOpg) from each sample were separated on a 10% denaturing SDSpolyacrylamide gel, then electrophoretically transferred to a nitrocellulose membrane and
incubated with monoclonal anti-PKCa antibody. Antigen/antibody complexes were

detected with Amersham’s enhanced chemiluminescence kit Lane 1; Rat brain, Lane 2;
wild type A7r5 cells, Lane 3; cells transfected with pSV-Neo only, Lane 4; PKCa

overexpression clone M , Lane 5; PKCa overexpression clone H. B: Quantification of
PKCa specific bands was performed by densitometry with the PKCa level in wild type
cells arbitrarily set at one.
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Fig. 27 Northern blot analysis of PKCa overexpression clones. A: PKCa mRNA from

wild type, (lane 1), Neo (lane 2), clone M (Lane 3), and clone H (lane 4). Total RNA (25
pg/lane) was separated on a formaldehyde agarose gel and transferred to a nylon

membrane and probed with PKCa and GAPDH cDNA probes consecutively.

B.

Quantitative representation of PKCa mRNA levels in different clones. The integrated area

of PKCa mRNA levels were determined by densitometry and normalized to the GAPDH
signal, with the wild type level set arbitrarily at one.
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Fig. 28 A) Growth curves of PKCa overexpressing clones. Cells from wild type, Neo,
clone M and H were seeded at 5,000 cells/cm2 and counted at 2 day intervals. Each point
is presented as the mean of 12 wells ± S.D. * and+ indicate a significant difference from
wild type, and between clone M and clone H respectively, (P< 0.05). B) Scatterplot
showing the correlation between PKCa levels and growth rates of eight different
overexpression clones relative to wild type A7r5 cells. Cells were counted at the sixth day
after seeding. Cell numbers and PKCa levels are expressed as the ratio of wild-type
control. The open circle indicates the neo clone; closed circles indicate different PKCaoverexpressing clones.
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Fig. 29 Morphological changes caused by PKCa overexpression. Cells were grown to
confluence in 10% FBS medium and photographed with a phase contrast microscope: A:

Wild type A7r5 cells, B: A7r5 cells transfected with pSV-Neo only, C: Cells from clone

M, which has four-fold PKCa overexpression, D: Cells from clone H which has ten fold

PKCa overexpression. Magnification: x200.
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Fig. 30 A) Western blot analysis of differentiation marker proteins (vinculin, desmin, aactin), P-actin and total actin from PKCa overexpression clones. Equal amounts of protein
from each sample were separated on 10% denaturing SDS-polyacrylamide gels, then
electrophoretically transferred to a nitrocellulose membrane and incubated with
monoclonal antibodies purchased from Sigma. Antigen/antibody complexes were detected
with Amersham’s enhanced chemiluminescence kit. Lane 1: Wild type A7r5 cells , Lane
2: A7r5 cells transfected with neomycin vector alone, Lane 3: PKCa overexpression clone
M, and Lane 4: PKCa overexpression clone H. B) Scatterplot showing the correlation
between PKCa and a-actin levels as the ratio to wild-type A7r5 cells. The open circle
indicates the neo clone; closed circles indicate eight different PKCa-overexpressing clones.
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overexpressing clones (Fig. 30). Clone M had about 80% of the a-actin level compared to

the neomycin vector transfected or wild type controls; whereas, clone H exhibited only

about 8% of the control level. Western blot analysis showed that the total actin level was
decreased by the overexpression of PKCa (Fig. 30A) by about 20% of control in clone M

and 60% in clone H. Further studies of all available clones showed that decreased a-actin

levels roughly correlated to increased PKCa levels (Fig. 30B). By comparison, the protein
level of P-actin was unchanged in PKCa overexpressing clones (Fig. 30A), suggesting that

the smooth muscle a-actin isoform is specifically regulated by PKCa. This was confirmed
by Northern blot analysis which showed that mRNA levels of a-actin, after correcting for

the amount of RNA in each sample (GAPDH), were downregulated in M and H clones
with no changes in the level of p-actin mRNA (Fig. 31).

A7r5 smooth muscle cells express 5 different protein kinase C isozymes al

detected by Western Blot analysis (PKC P, 8, 8, and Q (Fig. 32). Protein levels of PKCP,

PKC8 and PKC£ were not changed by the PKCa overexpression. The amount of PKCe
varied between different clones. However, examination of all available PKCa
overexpressing clones and the neomycin-resistant control clones suggested that the

differences

were due to clonal selection and were not directly related to PKCa

overexpression. In addition, the changes of cell growth rate and alpha actin levels in the

total array of clones available did not correlate with the PKCe levels, providing further
evidence that the effects observed were mainly related to PKCa overexpression (data not

shown).
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Fig. 31 Northern blot analysis of a- and P-actin mRNA levels in PKCa overexpression

clones. A: Total RNA (25pg/lane) from wild type (lane 1), Neo (lane 2), clone M (lane
3), clone H (lane 4) were isolated and separated in a formaldehyde agarose gel and probed

with actin and GAPDH cDNA probes consecutively. B: Quantitative representation of
a-actin (■) and P-actin

(□) mRNA levels in different clones.

RNA levels were

determined by densitometry and normalized to the GAPDH signal. The a-actin and p-actin
mRNA levels from wild type A7r5 cells were set as 100%.
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Fig. 32 Effect of PKCa overexpression in A7r5 cells on the protein levels of PKC
isoforms. Equal amounts (lOOpg) of protein from each sample were separated on a 10%

denaturing SDS-polyacrylamide gel, then electrophoretically transferred to a nitrocellulose
membrane and incubated with monoclonal antibodies specific for different PKC isoforms.

Antigen/antibody

complexes

were

detected

with

Amersham’s

enhanced

chemiluminescence kit. Lane 1: Rat brain served as positive control, Lane 2: Wild type
A7r5 cells, Lane 3: A7r5 cells transfected with neomycin vector alone, Lane 4: PKCa
overexpression clone M, and Lane 5: PKCa overexpression clone H.
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It is known that PKCa can regulate the expression and function of the nuclear
oncogene-encoded proteins c-Fos and c-Jun. These proteins are components of the AP-1

transcription factor thought to be important in regulating both cell proliferation and

differentiation (Kvantaand Fredholm, 1993; Okazaki et al., 1992). Nuclear extracts from
wild type and PKCa overexpressing clones yielded three protein-DNA complexes when
incubated with an oligonucleotide containing a consensus AP-1 element (Fig. 33A). The

specificity of these complexes was demonstrated by experiments which showed that

competition with a 50-fold or 1 OO-fold excess of non-radioactive AP-1 oligonucleotide but
not a 50-fold or 1 OO-fold excess of mutant AP-1 oligonucleotide abolished the appearance

of these three complexes (Fig. 33B). In order to detect the relatively low binding signal
of wild type nuclear extract, it was necessary to overexpose panel B as compared to panel

A. Even with this overexposure the signal was found to be completely competed out by
the excess of cold oligonucleotides in all three clones examined. Nuclear extracts from
wild type cells had less intense AP-1 binding compared to other nuclear extracts. Clone M

showed all three complexes; whereas, Clone H showed intense binding only of complexes
2 and 3. Short term PDB treatment generally increased the binding in all samples. These

data suggest that overexpression of PKCa either changed the binding intensity or the
binding pattern of nuclear proteins to oligonucleotides containing AP-1 consensus
sequence in A7r5 cells.
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Fig. 33 Electrophoretic mobility shift analysis of nuclear factors from wild type, clone M,
and clone H binding to oligonucleotides containing an AP-1 consensus sequence. A) Cells
from each clone were grown to confluence then either treated with IO-6 M PDB or vehicle
for 45 mins prior to isolation of nuclear proteins. The radiolabeled AP-1 oligonucleotides
were incubated with lOpg of nuclear proteins, and then separated in 5% acrylamide gel.
B) To show the specificity of these complexes for the oligonucleotides, competition
reactions were performed with 50-fold and 100-fold molar excess of non-radioactive wild
type or mutant oligonucleotides relative to radiolabeled oligonucleotides. The position of
the three principal nucleoprotein/oligonucleotide complexes are indicated by arrows. Panel
B was overexposed as compared to Panel A in order to detect weak wild type complex
formation.
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Discussion

In normal arteries, vascular smooth muscle cells exhibit a nonproliferating, highly

differentiated “contractile” phenotype. These cells synthesize cell-specific proteins such
as myosin, actin, a variety of calcium binding regulatory proteins, and ion channel

proteins, which allow them to contract in response to external stimuli. Maintaining an

arterial segments from an animal under “optimal” in vitro conditions results in the rapid
deterioration of contractile responsiveness. Moreover, the dispersal of smooth muscle

cells in cell culture leads to a dramatic loss of these signature characteristics as the cells

dedifferentiate to the “secretory” phenotype. Because smooth muscle cells exhibit such

plasticity of phenotype with changes occurring through a continuum from the proliferative
“secretory” to the non-proliferative “contractile” mode, it has been suggested that

modulation may represent a better term than dedifferentiation to indicate the range of

changes in phenotype (Chamley-Campbell et al., 1981). The ability of smooth muscle
cells to contract in response to agonist stimulation represents an ultimate marker of the

“contractile” phenotype. Thus, contractile function represents the most sensitive indicator

of the differentiated state of smooth muscle. On the other hand, growth rate can also be
considered as another marker for differentiation, as smooth muscle cells enter the cell

cycle and begin to proliferate under subcultured or pathological conditions.

The ready alteration of the phenotypic state of smooth muscle in vitro clearly
indicates the existence of in vivo mechanisms for maintaining smooth muscle cells in the
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highly differentiated contractile state. The results of our organ culture study are consistent
with the loss of modulation of contractile function in vitro with at least partial restoration

of responsiveness by the addition of adult rat plasma to the culture media (Fig. 1). This
further suggests that circulating plasma factor(s) play an important role in the long-term

modulation of contractile function in vascular smooth muscle. The beneficial effects of
RA on the preservation of the contractile response of rat aortic rings in organ culture
suggest that plasma retinoids may function as long-term modulatory factors of vascular

smooth muscle in vivo. The retinoids represent a family of natural compounds, found in
high concentration in plasma (Rogers et al., 1993), effect a wide variety of developmental
changes in normal and malignant cell types (Braunhut and Moses, 1994). Recent reports

have demonstrated that RA, a metabolite of retinol, induced the expression of smooth

muscle characteristics in a clonal cell line derived from multipotential embryonal

carcinoma cells (Blank et al., 1995) and induced a more differentiated phenotype in
subcultured, proliferating smooth muscle cells derived from rat thoracic aorta (Haller et
al., 1995). In our study, RA was only marginally effective in preserving the contractile

competence of aortic rings cultured in protein-free media. However, RA in combination

with plasma-supplemented media caused the full restoration of the contractile response
to potassium (Figs.2A,3A) and supramaximal responses to phorbol 12,13-dibutyrate

(Figs.2B,3B), suggesting that several factors are involved in the modulation of contractile
function. Alternatively, the results may reflect the interaction of RA with plasma proteins

that regulate plasma retinoid levels and cellular availability of these compounds
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(Bloomhoff et al., 1991; Rogers et al., 1993). Along with its effects on contractile

function, RA also inhibited smooth muscle cell proliferation (Fig. 7 and 8), another

relatively sensitive indicator for phenotype modulation. Low concentrations of RA (10'
8M) were able to exert this inhibitory effect in vitro, further indicating its importance in

vivo where levels of 4-14x1 O'9 M RA are found in human and rat plasma (Cullum and

Zile, 1985; de Leenher et al., 1982).

There is convincing evidence to suggest that the RA modulation of phenotype L
vascular smooth muscle involves an increase in the expression of protein kinase C (PKC).

Incubation of smooth muscle with RA resulted in a direct increase of PKCa (Fig 6),
PKCe and PKC8 (Fig. 9). Conversely, insertion of the PKCa gene into A7r5 smooth

muscle cells caused decreased growth compared to control cells (Fig. 28), suggesting a
causal relationship between PKC expression and the differentiation of smooth muscle
cells. RA supplements, which increase PKC expression, caused the enhancement of

contractile responsiveness in vitro (Figs. 1,2,3), and inhibition of subcultured cell growth

(Fig. 7 and 8); whereas, the prolonged incubation of tissues with phorbol 12,13-dibutyrate
to down-regulate PKC levels significantly reduced contractile responsiveness to potassium

in cultured rings (Fig. 5). The effect of long-term incubation with phorbol ester could be

reversed with nearly full restoration of the response to potassium to the level of freshly
excised tissues by an additional 24 hour incubation of these tissues with RA (Fig. 5).

Moreover, it was found that depletion of PKC in cultured smooth muscle cells resulted

in a depressed expression of desmin and a-actin (Fig. 11), which are essential for smooth
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muscle contractile function. These results are consistent with a direct role of PKC in the
modulation of smooth muscle differentiation in terms of contractile competence and
proliferation rate.

The endothelium may play a significant role in the long-term modulation of

contractile competence of aortic rings by RA in culture (Fig.4, Table 1). Removal of the

endothelium by intimal rubbing inhibited the restorative effect of plasma and RA on tissue
sensitivity and maximal responsiveness to potassium stimulation. A possible explanation
is that the endothelium releases compound(s) that have long-term effects on the contractile

competence of smooth muscle and RA regulates their secretion or production.

Alternatively, endothelium may release compounds that play an obligatory role in the

metabolism of retinoids or the access of RA to the underlying smooth muscle. The
possibility also remains that even gentle rubbing of the vessel lumen to remove

endothelium could result in mechanical stimulation or cellular damage that could
influence contractile function during 24 hours in organ culture.
Retinoic acid belongs to the Vitamin A family which is a group of blood-bom

agents that influence growth and differentiation of a wide variety of cell types (Sherman,

1986; Spom and Roberts, 1983). The circulating level of retinol, the parent molecule of
the retinoids, is rigorously maintained at a concentration of approximately 10‘6M
(Wahrendorf et al., 1986), and endothelial cells are exposed chronically to this relatively

high concentration of the compound. Available evidence indicates that retinol modulates

the morphology and growth of endothelial cells (Braunhut and Palomares, 1991),
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influencing their secretion of matrix-degrading proteases and metalloproteinase inhibitors
(Braunhut and Moses, 1994). In addition, reports indicating that retinol induces the
activation of latent TGF-P, a potent regulator of smooth muscle cell growth and

differentiation in endothelial cells (Kojima and Rifkin, 1993; Kojima et al., 1993), point
to a role for retinol in long-term vascular regulation.

The role of retinol in the regulation of vascular structure and function were

assessed both in long-term organ culture and cell culture systems in our study. Culture
of aortic rings for seven days in the basic L-15 media led to a pronounced loss (95%) in

the ability of the rings to develop tension in response to K+ depolarization (Fig. 12).

Because light and electron microscopic examination of cultured aortic tissue did not show
gross histomorphogenic deterioration, it would seem likely that at least part of the

deterioration in contractile function resulted from the dedifferentiation of the smooth
muscle cells and specific loss of key contractile proteins. The supplementation of the
media with plasma increased the contractile responsiveness to potassium in rings cultured
for 7 days, suggesting that circulatory factors contribute to the maintenance of the

contractile phenotype. The additional supplementation of the plasma-containing culture

media with a physiological concentration of retinol was found to further enhance tissue
responsiveness to the addition of potassium (Fig. 12). Moreover, this effect appeared to

depend upon an intact endothelium, as significant restoration of the contractile response
with plasma or retinol supplementation was lost when rings were denuded of endothelium

prior to culture for 7 days (Table 4). The importance of the endothelium in maintaining
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the underlying smooth muscle responsiveness to potassium was also confirmed by the
finding that the rubbed tissue responded more poorly. Maximum contraction was
attenuated compared to the unrubbed 7-day cultured controls.

Retinol and long-term treatment with phorbol 12, 13-dibutyrate had several
contrasting effects on the morphology of the endothelial cells of aortic segments in culture
(Fig. 14). The most dramatic change appeared at the subendothelial space which is

primarily generated through the secretion of proteins by the endothelial cells. Retinol
supplementation of the culture media caused an increase in the thickness of the

subendothelial space, while treatment with phorbol resulted in nearly the complete loss
of this proteinaceous layer after 7 days in culture. These findings in tissues are consistent
with the observations of endothelial cells in culture (Braunhut and Moses, 1994) showing

that retinol modulates the secretion pattern of these cells in a fashion that would favor
accumulation of extracellular matrix.

In order to more rigorously explore the relationship between the interaction of the
endothelium in the growth and differentiation of the underlying smooth muscle cells, we
employed conventional cell culture techniques to decrease the complexity and

heterogeneity associated with whole tissue culture. Treatment of the A7r5 cells with
retinol showed no obvious morphological effects and was found to have no effects on

growth at concentrations of up to 10‘5M. This indicates that retinol has no direct effect
on smooth muscle cell growth, which confirms the findings of Hayashi et al. (1995).
Moreover, coupled with the finding that even low concentrations of all-trans RA
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significantly inhibited A7r5 smooth muscle cell growth (Fig. 7), the absence of an effect
of retinol strongly suggests that smooth muscle cells do not metabolize retinol to RA to

any significant degree. In contrast, treatment with physiological concentrations of retinol

was found to induce significant changes in the morphological appearance of endothelial
cells. Specifically, endothelial cells were more rounded and occupied a larger area. In

our hands, control BAEC tended to overgrow confluence so that cells have overlapping

protrusions. The presence of retinol eliminated this overgrowth with the cells becoming
quiescent when confluence was reached (Fig. 16).
The endothelium lining the blood vessel is known to release a number oi

compounds that influence the growth of isolated vessel smooth muscle cells (Dodge et al.,
1993; Peiro et al., 1995). The release of these factors is thought to be cell density

dependent (Dodge et al., 1993). Subconfluent, proliferating cells favor the release of
growth promoting factors; whereas, postconfluent endothelial cells release growth

inhibitors. Possible growth inhibitory compounds released from the endothelium include
heparin sulfate proteoglycan, nitric oxide, prostacyclin, transforming growth factor-P, and

a presently unidentified endothelial cell-derived smooth muscle cell growth inhibitor
(Dodge et al., 1993).
The present work indicates that the coculture of bovine endothelial cells grown to

postconfluence inhibits the growth of smooth muscle cells of the A7r5 cell line (Fig. 17).
Furthermore, the effect of coculture was significantly increased by treatment of the

endothelial cells with physiological concentrations of retinol. By comparison, the addition
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of retinol directly to A7r5 cell cultures had no effect on growth (Fig. 15). Taken together,

the results suggest that circulating retinol could play an important role in the regulation

of smooth muscle cell growth through the modulation of endothelial release of growth
inhibitors or the reduced secretion of growth stimulators. The finding that conditioned

medium from retinol-treated but not control endothelial cells significantly inhibited A7r5
cell growth (Fig. 18) further suggests that the growth inhibitory influence of untreated,

control endothelial cells was either very close to threshold activity or that the responsible
factor(s) was unstable. Because the conditioned medium was stored and subjected to at
least one freeze-thaw cycle, the results suggest that the factor released from endothelial
cells in response to retinol was relatively stable and is not likely to be a compound such

a nitric oxide (NO), which would be expected to be quickly degraded. The absence of
growth inhibitory activity in conditioned medium from control endothelial cell cultures
but not retinol-treated cultures also makes it most likely that the inhibition of smooth
muscle cell proliferation was due to the release of an inhibitor as opposed to decreased

secretion of growth stimulatory factors.
The identity ofthe retinol-stimulated endothelium-derived growth inhibitory factor
is not known. One possibility is that retinol could cause the increased release of known

endothelium-derived growth-inhibitory factors. One likely candidate that meets the
description of a stable endothelium-derived cell growth inhibitor influenced by retinol is

transforming growth factor-P (TGF-P). It has been reported that retinol can cause more

than a 100-fold increase of TGF-P peptide in keratinocytes (Glick et al., 1989) and
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significant increases in the mRNA levels of TGF-0 in endothelial cells (Heine et al.,

1985). TGF-P is a potent growth inhibitor of smooth muscle cells (D’Amore and Smith,
1993). Alternatively, the endothelium can convert retinol to a variety of active metabolites

including retinoic acid to influence the differentiation state of smooth muscle cells. To our
knowledge, no information is available on this aspect, thus it is necessary to explore the
metabolism of retinol in vascular endothelial cells.

Bovine aortic endothelial cells were shown to contain different metabolites of
retinol compared to A7r5 smooth muscle cells (Fig. 20, 21). One metabolite of retinol
eluted with a retention time of 8 minutes in HPLC from cell extracts of BAECs was not

identified in comparisons with known metabolites. BAECs also released several retinol

derivatives directly into the cell culture medium (Fig. 24, 25). Together with the finding
that CRBP (Neuville et al., 1997) and CRABP-1 present in endothelial cells (Kooistra et
al., 1995), these data suggest that endothelial cells have the ability to process retinol into

other, potentially active, derivatives; on the other hand, smooth muscle cells do not

express CRBP (Neuville et al., 1997) and do not respond to even high concentrations of
retinol. However, the metabolites obtained from BAEC failed to inhibit smooth muscle
cell growth (Fig. 26). The lack of growth inhibitory activity of these compounds further

indicates that alteration of non-retinol inhibitory factor synthesis/release might be the

major effect of retinol on endothelium. Alternatively, retinol metabolites could affect

smooth muscle cell differentiation through mechanisms not tested here, as proliferation
was the only indicator we used to measure their activity.
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Our data strongly indicated that PKC is involved in retinoid effects on smooth

muscle cells. Manipulating PKC levels by using RA and phorbol ester altered aortic
i

responses to potassium; whereas, RA treatment increased PKC expression and inhibited
smooth muscle cell growth. Because smooth muscle cells express at least five PKC

isoforms and retinoic acid can change the expression of several isoforms (Fig. 6 and 9),

it is necessary to understand the specific actions of individual isoforms to interpret the
effect of retinoids. Stable expression in A7r5 smooth muscle cells was used in our

experiments to achieve this goal.

Two clones were selected for study, a moderately overexpressing (Clone M, 4
fold) and a highly overexpressing (Clone H, 10-fold) PKCa clone. Both of these PKCa

overexpressing clones showed profound morphological and cell growth changes in the

A7r5 smooth muscle cell line. The growth rate and confluent density of both clone M and
clone H were reduced in medium supplemented with 10% FBS as compared to the wild
type or neomycin control cells. This supports the contention that PKCa negatively
regulates smooth muscle cell proliferation.

Because slow growth is often accompanied by a more differentiated phenotype,
we studied the possibility that PKCa overexpression may have effects on the levels of

selected smooth muscle cell differentiation markers. The levels of desmin and vinculin,
two cytoskeleton proteins previously shown to vary with the differentiated state of the

smooth muscle cell (Orlandi et al., 1994; Shanahan et al., 1993), were found to be
unaffected by the PKCa overexpression. It was further found that a-actin, a differentiation
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marker protein specific to smooth muscle cells and directly involved in contraction, was
expressed at reduced levels in apparent correlation with the degree of PKCa

overexpression in the clones investigated. PKCa downregulation of a-actin levels is
surprising in light of the work by Haller et al. (1995), which showed that direct
microinjection of PKCa into smooth muscle cells increased a-actin levels as measured by

immunofluorescence. These contradictory observations could result from our use of

embryonic smooth muscle derived A7r5 cells versus adult rat aorta-derived cells studied
by Haller et al. (1995b). Porreca et al. (1993) showed that PKC has opposite cellulai

effects in smooth muscle cells isolated from young and aged rats. In addition, the method
of PKCa introduction into cells is different between the two studies. Haller et al. (1995b)

found that injected PKCa was diffusely localized in the cytoplasmic compartment;
whereas, overexpressed PKCa is processed by the cell sorting machinery and has been

reported to be associated with the endoplasmic reticulum in NIH 3T3 Cells (Goodnight
et al., 1995). It has been recently proposed that PKC isotype substrate specificity is a

consequence of isotype-specific localization of the various PKC isoforms (Jaken, 1996).

If this is the case, then correct localization of PKC is a prerequisite for drawing firm
conclusions regarding PKC isotype-specific effects.

AP-1 is a transcription complex which has been found to be rapidly induced by

growth factors through a PKC-dependent pathway (Karin, 1990). The AP-1 family of
transcriptional factors usually form dimers and stimulate transcription through interaction

with a specific DNA sequence known as the AP-1 site. It has also been found that Fos and
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Jun proteins can dimerize with proteins of cAMP responsive element binding protein

(CREB) and mediate the growth inhibitory effects of cAMP in smooth muscle cells
through activation of growth inhibitory genes (Nilsson et al., 1994). In order to gain

insight into changes which occur in PKCa overexpressing A7r5 cell nuclear/transcription
regulation, we assessed binding patterns of nuclear extracts to an oligonucleotide

containing an AP-1 consensus sequence. PKCa overexpression was found to dramatically

alter both the intensity and the pattern of protein-DNA complexes which bound to the AP1 oligonucleotide.

The elevation of PKCa in both moderately (M) and highly (H)

overexpressing clones led to a general increase in binding, suggesting the presence of
increased active AP-1 complex and /or the level of AP-1 components. Consistent with

our data, Borner et al. (1995) found that overexpression of PKCa in rat fibroblast cells
increased

the expression of c-fos and c-jun while concurrently inhibiting growth.

Although the components of the binding complexes need further study and identification
before any firm conclusions can be drawn, we feel that the remarkable changes of AP-1

binding are suggestive for the role of AP-1 in the variety of effects produced by PKCa
overexpression.

AP-1 protein may also participate in the regulation of smooth muscle a-actin
expression. Two serum response elements (SRE) have been identified in the promoter

region of smooth muscle a-actin and have been shown to be important in the regulation
of a-actin expression. Many growth factors activate the SRE through the binding of serum

response factors (SRF). Shimizu et al. (1995) showed that SRF binds to the core SRE
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sequence, termed CArG box, and activates a-actin expression. Bushel et al. (1995)
further showed that cotransfection of c-fos and c-jun repress the a-actin promotor through

SREs, suggesting that AP-1 protein might be a negative factor that either directly binds
to SRE or interacts with SRF to mediate repression of a-actin promotor activity. The gel

shift analysis of the PKCa overexpressing clones is clearly indicative of changes in active
transcription complexes with AP-1 like binding activity and could serve as the molecular
mechanism of PKCa regulation of a-actin expression in A7r5 cells. Future studies are

needed to identify the nuclear factors interacting with AP-1 consensus sequence and how
PKCa regulates the function of these transcription factors.
The decrease of smooth muscle-specific a-actin in the overexpression clones in

combination with the morphology changes suggest that these cells adopted a less

differentiated state in the presence of high PKCa levels. On the other hand, PKCa
overexpression caused a decreased growth rate. It seems that proliferation and

differentiation were uncoupled in A7r5 cells by an unphysiological amount of PKCa.
Overexpression of PKC8 in A7r5 cells also inhibited proliferation and arrested cells at

lower cell density (Fukumoto et al., 1997). The ability of RA to increase the expression

of PKCa and PKC8 levels in A7r5 smooth muscle cells is probably responsible for the
regulation of cell proliferation, as changes of nuclear factors have been observed in

overexpression clones (Fig. 33; Fukumoto et al., 1997). In contrast, PKCe, when added

into permeabilized single vascular smooth muscle cells, induced contractile responses and

phosphorylated calponin, alleviating the inhibition of cross bridge cycling (Walsh et al.,
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1996). We speculate that RA may preserve the contractile competence of smooth muscle,
to some extent, through the up-regulation of PKCe.
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